<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006108.pub4" GROUP_ID="MENSTR" ID="413305091507194639" MERGED_FROM="" MODIFIED="2014-11-26 01:38:05 +0000" MODIFIED_BY="Helen Nagels" REVIEW_NO="AMD1211" REVMAN_SUB_VERSION="5.2.6 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="10.0">
<COVER_SHEET MODIFIED="2014-11-26 01:38:05 +0000" MODIFIED_BY="Helen Nagels">
<TITLE>Exercise for vasomotor menopausal symptoms</TITLE>
<CONTACT MODIFIED="2014-11-26 01:38:05 +0000" MODIFIED_BY="Helen Nagels"><PERSON ID="583A010C82E26AA200D602253B06B577" ROLE="AUTHOR"><FIRST_NAME>Amanda</FIRST_NAME><LAST_NAME>Daley</LAST_NAME><POSITION>Senior Lecturer</POSITION><EMAIL_1>a.daley@bham.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Primary Care Clinical Sciences</DEPARTMENT><ORGANISATION>College of Medical and Dental Sciences, University of Birmingham</ORGANISATION><CITY>Birmingham</CITY><ZIP>B15 2TT</ZIP><REGION>England</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 121 4143762</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-11-26 01:38:05 +0000" MODIFIED_BY="Helen Nagels"><PERSON ID="583A010C82E26AA200D602253B06B577" ROLE="AUTHOR"><FIRST_NAME>Amanda</FIRST_NAME><LAST_NAME>Daley</LAST_NAME><POSITION>Senior Lecturer</POSITION><EMAIL_1>a.daley@bham.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Primary Care Clinical Sciences</DEPARTMENT><ORGANISATION>College of Medical and Dental Sciences, University of Birmingham</ORGANISATION><CITY>Birmingham</CITY><ZIP>B15 2TT</ZIP><REGION>England</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 121 4143762</PHONE_1></ADDRESS></PERSON><PERSON ID="3AD8E23782E26AA200426E055D8F8DE3" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Helen</FIRST_NAME><LAST_NAME>Stokes-Lampard</LAST_NAME><POSITION>Clinical Senior Lecturer</POSITION><EMAIL_1>h.j.stokeslampard@bham.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Primary Care Clinical Sciences</DEPARTMENT><ORGANISATION>College of Medical and Dental Sciences, University of Birmingham</ORGANISATION><CITY>Birmingham</CITY><ZIP>B15 2TT</ZIP><REGION>England</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+01214142953</PHONE_1><FAX_1>+01214146571</FAX_1></ADDRESS></PERSON><PERSON ID="z1308150609080963966851177721070" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Adèle</FIRST_NAME><LAST_NAME>Thomas</LAST_NAME><POSITION>HDR Learning Advisor</POSITION><EMAIL_1>thomas.adele@rocketmail.com</EMAIL_1><EMAIL_2>a.thomas.2@bham.ac.uk</EMAIL_2><ADDRESS><DEPARTMENT>Higher Degree Research Office</DEPARTMENT><ORGANISATION>Macquarie University</ORGANISATION><ADDRESS_1>Balaclava Road</ADDRESS_1><CITY>North Ryde</CITY><ZIP>2109</ZIP><REGION>New South Wales</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 2 9850 7111</PHONE_1><FAX_1>+61 2 9850 7433</FAX_1></ADDRESS></PERSON><PERSON ID="3AD8E08182E26AA200426E0584198FBE" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Christine</FIRST_NAME><LAST_NAME>MacArthur</LAST_NAME><POSITION>Professor of Maternal and Child Epidemiology</POSITION><EMAIL_1>c.macarthur@bham.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Public Health, Epidemiology and Biostatistics</DEPARTMENT><ORGANISATION>College of Medical and Dental Sciences, University of Birmingham</ORGANISATION><CITY>Birmingham</CITY><ZIP>B15 2TT</ZIP><REGION>England</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+64 0121 414 6770</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-10-22 14:54:02 +1300" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="3" MONTH="3" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="3" MONTH="3" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="3" MONTH="3" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="11" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-11-11 21:19:25 +1300" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-10-22 14:53:39 +1300" MODIFIED_BY="Helen E Nagels">
<DATE DAY="3" MONTH="3" YEAR="2014"/>
<DESCRIPTION>
<P>Review updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-11-11 21:19:25 +1300" MODIFIED_BY="[Empty name]">
<DATE DAY="3" MONTH="3" YEAR="2014"/>
<DESCRIPTION>
<P>2 new studies were added to the review (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>), and 3 previously included studies were deemed to be ineligible and have been excluded (<A HREF="https://archie.cochrane.org/sections/documents/view?version=z1408201216300744197831061868255&amp;format=REVMAN#STD-Bergstr_x00f6_m-2005">Bergström 2005</A>; <A HREF="https://archie.cochrane.org/sections/documents/view?version=z1408201216300744197831061868255&amp;format=REVMAN#STD-Chatta-2008">Chatta 2008</A>; <A HREF="https://archie.cochrane.org/sections/documents/view?version=z1408201216300744197831061868255&amp;format=REVMAN#STD-Moriyama-2008">Moriyama 2008</A>), but this did not lead to a change in conclusions</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2014-11-11 21:21:07 +1300" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2014-11-11 21:20:29 +1300" MODIFIED_BY="[Empty name]">
<DATE DAY="8" MONTH="8" YEAR="2011"/>
<DESCRIPTION>
<P>Date field ('Assessed as Up-to-date') was corrected</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2014-11-11 21:19:47 +1300" MODIFIED_BY="[Empty name]">
<DATE DAY="6" MONTH="4" YEAR="2011"/>
<DESCRIPTION>
<P>Conclusions have changed since the review was published in Issue 4, 2007</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2014-11-11 21:20:36 +1300" MODIFIED_BY="[Empty name]">
<DATE DAY="25" MONTH="1" YEAR="2011"/>
<DESCRIPTION>
<P>Contact details have been updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-11-11 21:20:00 +1300" MODIFIED_BY="[Empty name]">
<DATE DAY="16" MONTH="3" YEAR="2010"/>
<DESCRIPTION>
<P>Updated review includes 5 new studies</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2014-11-11 21:21:07 +1300" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Review has been converted to new review format in this update</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2014-11-11 21:20:50 +1300" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="8" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendments have been made</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2010-09-22 09:41:14 +1200" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2010-09-22 09:41:14 +1200" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2010-09-22 09:41:14 +1200" MODIFIED_BY="[Empty name]">
<NAME>University of Birmingham</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>Host institution of authors </P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2010-01-21 03:03:33 +1300" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2010-01-21 03:03:33 +1300" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-11-24 11:51:30 +1300" MODIFIED_BY="Helen E Nagels">
<SUMMARY MODIFIED="2014-11-12 14:36:15 +1300" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2014-05-09 12:49:37 +1200" MODIFIED_BY="[Empty name]">Exercise for vasomotor menopausal symptoms</TITLE>
<SUMMARY_BODY MODIFIED="2014-11-12 14:36:15 +1300" MODIFIED_BY="[Empty name]">
<P>
<B>Review question:</B> Is exercise an effective treatment for reducing hot flushes/night sweats in menopausal women with hot flushes?</P>
<P>
<B>Background:</B> Studies suggest that a high proportion of menopausal women will experience hot flushes and night sweats. Hormone therapy is considered to be the most effective treatment for symptoms. However, studies have reported that hormone therapies are potentially associated with some negative health effects; many women are now choosing not to use these and are looking for alternatives. Therefore, it is increasingly important to identify lifestyle modifications that may help to reduce the frequency and severity of hot flushes and night sweats. Review authors from The Cochrane Collaboration examined the evidence, which is current to March 2014.</P>
<P>
<B>Study characteristics:</B> Five studies randomly assigned 762 women experiencing hot flushes/night sweats. Three trials and two trials, respectively, were included in pooled comparisons of exercise versus control (n = 454 women) and exercise versus yoga (n = 279 women). One small study (14 women) compared exercise versus hormone therapy.</P>
<P>
<B>Key findings:</B> When exercise was compared with no intervention, no evidence was found of any difference in their effect on hot flushes. One small study suggested that HT is more effective than exercise. Evidence was insufficient to show whether exercise was more effective than yoga. None of the trials found any evidence of differences between groups with respect to adverse effects, but data were very scanty.</P>
<P>
<B>Quality of the evidence:</B> The methodological quality of the studies was variable. We assessed the evidence as of low quality: The main limitations were poor reporting of study methods, inconsistent results and lack of precision.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-11-12 14:35:13 +1300" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2014-11-12 14:18:26 +1300" MODIFIED_BY="[Empty name]">
<P>Evidence suggests that many perimenopausal and early postmenopausal women will experience menopausal symptoms; hot flushes are the most common. Symptoms caused by fluctuating levels of oestrogen may be alleviated by hormone therapy (HT), but a marked global decline in its use has resulted from concerns about the risks and benefits of HT. Consequently, many women are seeking alternatives. As large numbers of women are choosing not to take HT, it is increasingly important to identify evidence-based lifestyle modifications that have the potential to reduce vasomotor menopausal symptoms.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2014-08-20 22:20:52 +1200" MODIFIED_BY="Helen E Nagels">
<P>To examine the effectiveness of any type of exercise intervention in the management of vasomotor symptoms in symptomatic perimenopausal and postmenopausal women.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-11-12 14:19:01 +1300" MODIFIED_BY="[Empty name]">
<P>Searches of the following electronic bibliographic databases were performed to identify randomised controlled trials (RCTs): Cochrane Menstrual Disorders and Subfertility Group Specialised Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (Wiley Internet interface), MEDLINE (Ovid), EMBASE (Ovid), PsycINFO (Ovid), the Science Citation Index and the Social Science Citation Index (Web of Science), the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (Ovid) and SPORTDiscus. Searches include findings up to 3 March 2014.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2014-11-12 07:21:06 +1300" MODIFIED_BY="[Empty name]">
<P>RCTs in which any type of exercise intervention was compared with no treatment/control or other treatments in the management of menopausal vasomotor symptoms in symptomatic perimenopausal/postmenopausal women.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-11-12 14:34:24 +1300" MODIFIED_BY="[Empty name]">
<P>Five studies were deemed eligible for inclusion. Two review authors independently selected the studies, and three review authors independently extracted the data. The primary review outcome was vasomotor symptoms, defined as hot flushes and/or night sweats. We combined data to calculate standardised mean differences (SMDs) with 95% confidence intervals (CIs). Statistical heterogeneity was assessed using the I<SUP>2</SUP> statistic. We assessed the overall quality of the evidence for main comparisons using GRADE (Grades of Recommendation, Assessment, Development and Evaluation) methods.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-11-12 14:35:13 +1300" MODIFIED_BY="[Empty name]">
<P>We included five RCTs (733 women) comparing exercise with no active treatment, exercise with yoga and exercise with HT. The evidence was of low quality: Limitations in study design were noted, along with inconsistency and imprecision. In the comparison of exercise versus no active treatment (three studies, n = 454 women), no evidence was found of a difference between groups in frequency or intensity of vasomotor symptoms (SMD -0.10, 95% CI -0.33 to 0.13, three RCTs, 454 women, I<SUP>2 </SUP>= 30%, low-quality evidence). Nor was any evidence found of a difference between groups in the frequency or intensity of vasomotor symptoms when exercise was compared with yoga (SMD -0.03, 95% CI -0.45 to 0.38, two studies, n = 279 women, I<SUP>2 </SUP>= 61%, low-quality evidence). It was not possible to include one of the trials in the meta-analyses; this trial compared three groups: exercise plus soy milk, soy milk only and control; results favoured exercise relative to the comparators, but study numbers were small. One trial compared exercise with HT, and the HT group reported significantly fewer flushes in 24 hours than the exercise group (mean difference 5.8, 95% CI 3.17 to 8.43, 14 participants). None of the trials found evidence of a difference between groups with respect to adverse effects, but data were very scanty.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-11-12 07:39:52 +1300" MODIFIED_BY="[Empty name]">
<P>Evidence was insufficient to show whether exercise is an effective treatment for vasomotor menopausal symptoms. One small study suggested that HT is more effective than exercise. Evidence was insufficient to show the relative effectiveness of exercise when compared with HT or yoga.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-11-24 11:51:30 +1300" MODIFIED_BY="Helen E Nagels">
<BACKGROUND MODIFIED="2014-11-12 15:45:25 +1300" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2014-11-12 14:39:11 +1300" MODIFIED_BY="[Empty name]">
<P>Menopause is a significant event in most women's lives, as it marks the end of natural reproductive life. The perimenopausal and early postmenopausal period is typically characterised by fluctuating levels of endogenous oestrogen, which can give rise to symptoms that are severe and disruptive. Evidence suggests that a high proportion of perimenopausal and early postmenopausal women will experience some menopausal symptoms; hot flushes are common (<LINK REF="REF-Greendale-1999" TYPE="REFERENCE">Greendale 1999</LINK>). Large cultural differences are apparent in the experience of vasomotor symptoms; women living in Western industrialised countries are more likely to experience these than other populations of women (<LINK REF="REF-Gold-2004" TYPE="REFERENCE">Gold 2004</LINK>; <LINK REF="REF-Reed-2013" TYPE="REFERENCE">Reed 2013</LINK>). Hot flushes (called hot flashes in USA) occur as a sudden feeling of heat in the face, neck and chest (<LINK REF="REF-WHO-1996" TYPE="REFERENCE">WHO 1996</LINK>). Hot flushes are frequently accompanied by skin flushing and perspiration; a chill may follow as core body temperature drops (<LINK REF="REF-Greendale-1999" TYPE="REFERENCE">Greendale 1999</LINK>). Hot flushes can be occasional or frequent, can last a few seconds to an hour, may be spontaneous and unpredictable and can vary in severity (<LINK REF="REF-Freeman-1995" TYPE="REFERENCE">Freeman 1995</LINK>). Hot flushes that occur during the night are typically referred to as night sweats. Flushes and night sweats are of concern in themselves, but they also can disrupt sleep patterns and alter daily activities, which can lead to fatigue and decreased quality of life (<LINK REF="REF-NAMS-2002" TYPE="REFERENCE">NAMS 2002</LINK>). Hot flushes are thought to result from the brain's response to diminished hormones and hormonal fluctuations that occur during the menopause transition, which in turn leads to instability of thermoregulatory mechanisms that regulate temperature homeostasis in the hypothalamus (<LINK REF="REF-Freeman-2001" TYPE="REFERENCE">Freeman 2001</LINK>).</P>
<P>Hormone therapy (HT) (oestrogen or combined oestrogen-progestogen therapy) is the most common treatment for hot flushes; the North American Menopause Society (<LINK REF="REF-NAMS-2012" TYPE="REFERENCE">NAMS 2012</LINK>) supports its use in treating moderate to severe vasomotor symptoms. However, apparent benefits of HT have been questioned in the past decade because trials (<LINK REF="REF-Hulley-1998" TYPE="REFERENCE">Hulley 1998</LINK>; <LINK REF="REF-Viscoli-2001" TYPE="REFERENCE">Viscoli 2001</LINK>; <LINK REF="REF-WHI-2002" TYPE="REFERENCE">WHI 2002</LINK>) failed to demonstrate that HT is associated with secondary prevention of cardiovascular disease. These publications raised concerns about the risks and benefits of HT. Several other trials and observational studies (<LINK REF="REF-Holmberg-2004" TYPE="REFERENCE">Holmberg 2004</LINK>; <LINK REF="REF-Million-Women-Study-2003" TYPE="REFERENCE">Million Women Study 2003</LINK>; <LINK REF="REF-Rossouw-2002" TYPE="REFERENCE">Rossouw 2002</LINK>) have reported that HT may be linked with increased risk of certain diseases, including breast cancer. Whilst the reanalysis (<LINK REF="REF-Rossouw-2007" TYPE="REFERENCE">Rossouw 2007</LINK>) of the Women&#8217;s Health Initiative in 2007 provided evidence of coronary heart safety for users of HT younger than 60 years of age and within 10 years of the onset of menopause, previous uncertainty surrounding actual cost/benefit to be gained has left many women reluctant to take HT. Doctors are more cautious about prescribing HT, as demonstrated by the large reduction in prescriptions in recent years (<LINK REF="REF-Hersh-2004" TYPE="REFERENCE">Hersh 2004</LINK>; <LINK REF="REF-Lawton-2003" TYPE="REFERENCE">Lawton 2003</LINK>). In addition, evidence (<LINK REF="REF-Hope-1998" TYPE="REFERENCE">Hope 1998</LINK>) has suggested that some women report adverse effects when taking HT, which may preclude hormone use, and not all women are able to use HT. Consequently, many women are seeking alternatives (<LINK REF="REF-Daley-2006" TYPE="REFERENCE">Daley 2006</LINK>; <LINK REF="REF-Nelson-2005" TYPE="REFERENCE">Nelson 2005</LINK>; <LINK REF="REF-Posadzki-2013" TYPE="REFERENCE">Posadzki 2013</LINK>), and it has become increasingly important to identify other evidence-based interventions that have the potential to reduce vasomotor and other menopausal symptoms.</P>
</CONDITION>
<INTERVENTION MODIFIED="2014-11-12 15:44:23 +1300" MODIFIED_BY="[Empty name]">
<P>Numerous studies and reviews (<LINK REF="REF-Daley-2008" TYPE="REFERENCE">Daley 2008</LINK>; <LINK REF="REF-DH-2011" TYPE="REFERENCE">DH 2011</LINK>; <LINK REF="REF-Eriksen-2004" TYPE="REFERENCE">Eriksen 2004</LINK>) involving other populations have reported that physical activity and exercise participation may have positive effects on a range of other menopause-related symptoms and health outcomes such as cognitive functioning, depression, sleep patterns, fatigue, bone density, weight maintenance and cardiovascular disease. Thus, it is reasonable to investigate whether exercise will have an impact on menopausal vasomotor symptoms. In addition to providing significant physiological benefits (e.g. cardiovascular and bone health), exercise may represent one of the promising alternatives to HT and, if it is demonstrated to be effective in the treatment of vasomotor symptoms, offers an inexpensive intervention that typically has few known side effects. The Royal College of Obstetricians and Gynaecologists (<LINK REF="REF-RCOG-2006" TYPE="REFERENCE">RCOG 2006</LINK>) in the United Kingdom (UK) has advised (Scientific Advisory Committee Opinion Paper 6) that women who are more active tend to suffer less from the symptoms of menopause, and that the best type of activity is aerobic, sustained, regular exercise such as swimming and running.</P>
<P>Observational studies have reported inconsistent findings regarding the association between exercise and lower rates of vasomotor symptoms, although larger studies have tended to report positive associations, and smaller studies negative or no associations. Among women attending menopause clinics in Italy (n = 66,501), severe vasomotor symptoms were significantly more common in those reporting lower levels of regular physical activity (<LINK REF="REF-Progetto-Study-2005" TYPE="REFERENCE">Progetto Study 2005</LINK>). A similar association was found in a study of a multi-racial population of women (N = 12,245) (<LINK REF="REF-Gold-2000" TYPE="REFERENCE">Gold 2000</LINK>). A low vasomotor symptom score was found to be correlated with regular exercise and regular free-time activities (n = 4504) (<LINK REF="REF-Stadberg-2000" TYPE="REFERENCE">Stadberg 2000</LINK>).  A recent longitudinal study (13-year follow-up) has reported that exercise participation was associated with shorter symptom duration (<LINK REF="REF-Col-2009" TYPE="REFERENCE">Col 2009</LINK>), but the sample was small (n = 205). Other smaller observational studies (typically n &lt; 1500) have reported negative or no associations (<LINK REF="REF-Daley-2007a" TYPE="REFERENCE">Daley 2007a</LINK>; <LINK REF="REF-Sternfeld-1999" TYPE="REFERENCE">Sternfeld 1999</LINK>; <LINK REF="REF-Wilbur-1992" TYPE="REFERENCE">Wilbur 1992</LINK>), but these smaller studies generally have not considered relevant confounding variables. </P>
<P>Although large observational studies have indicated that exercise might be a useful intervention in helping to ameliorate vasomotor symptoms, these findings must be substantiated in randomised controlled trials (RCTs). In 2011 the Cochrane review titles "Exercise for the Management of Vasomotor Menopausal Symptoms" included six studies that were generally small.  Thus, no conclusions regarding the effectiveness of exercise as a treatment for vasomotor symptoms could be made by review authors at that time.  </P>
</INTERVENTION>
<THEORY MODIFIED="2014-11-12 15:45:25 +1300" MODIFIED_BY="[Empty name]">
<P>Plausible biological mechanisms are known by which exercise could reduce vasomotor and other menopausal symptoms. It has been hypothesised that endorphin concentrations in the hypothalamus decrease as oestrogen production declines, enhancing the release of norepinephrine and serotonin. Exercise may have a similar effect to HT in the amelioration of vasomotor symptoms by increasing hypothalamic and peripheral &#946;-endorphin production (<LINK REF="REF-Bortz-1981" TYPE="REFERENCE">Bortz 1981</LINK>). In addition, evidence suggests that as endorphins increase, the frequency and amplitude of luteinising hormone decrease, and this regulates gonadotropin-releasing hormone levels (<LINK REF="REF-Reid-1981" TYPE="REFERENCE">Reid 1981</LINK>). Research (<LINK REF="REF-Heitkamp-1996" TYPE="REFERENCE">Heitkamp 1996</LINK>) has shown that active individuals have higher basal levels of &#946;-endorphins than those who are inactive. Through these mechanisms, exercise may help to stabilise the thermoregulatory centre and diminish the risk of hot flushes. It has also been suggested that exercise can improve mental health outcomes by providing a distraction or &#8216;time out&#8217; strategy from daily worries (<LINK REF="REF-Bahrke-1978" TYPE="REFERENCE">Bahrke 1978</LINK>), and that exercise can enhance feelings of accomplishment among individuals, thereby improving self-esteem (<LINK REF="REF-Fox-2000" TYPE="REFERENCE">Fox 2000</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2014-11-12 08:38:32 +1300" MODIFIED_BY="[Empty name]">
<P>If shown to be effective, exercise might be an acceptable, low-cost, non-pharmacological treatment for vasomotor menopausal symptoms and an alternative to HT. Exercise may confer additional physical and mental health benefits (e.g. improve cardiovascular and bone health, decrease feelings of depression) for perimenopausal and early postmenopausal women.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2014-08-20 22:21:18 +1200" MODIFIED_BY="Helen E Nagels">
<P>To examine the effectiveness of any type of exercise intervention in the management of vasomotor symptoms in symptomatic perimenopausal and postmenopausal women.</P>
</OBJECTIVES>
<METHODS MODIFIED="2014-11-17 14:27:46 +1300" MODIFIED_BY="Helen E Nagels">
<SELECTION_CRITERIA MODIFIED="2014-11-12 15:47:10 +1300" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2014-11-12 08:39:00 +1300" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs) were eligible for inclusion. Cross-over trials were eligible for inclusion, but only data from the first phase were included in meta-analyses.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2014-11-12 15:46:07 +1300" MODIFIED_BY="[Empty name]">
<P>Studies of women with surgical or spontaneous menopause, in the perimenopausal or postmenopausal period, experiencing any vasomotor symptoms at baseline and recruited from any setting or population-based sample were eligible for inclusion.</P>
<P>Perimenopausal women were defined as women with spontaneous menopause who had experienced irregular menstruation within the previous 12 months. Postmenopausal women were defined as women with surgical or spontaneous menopause and amenorrhoea for longer than 12 months.</P>
<P>Women experiencing vasomotor symptoms due to breast cancer treatment and women taking any hormone therapy for any reason before the time of study entry were excluded.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2014-11-12 08:42:04 +1300" MODIFIED_BY="[Empty name]">
<P>Exercise was defined as structured exercise and/or physical activity achieved through active living. Trials that compared any type of exercise intervention with no active treatment or with other treatments were included.</P>
<P>Active treatments used as controls could include hormone therapy (HT), dietary supplementation, health education and alternative forms of exercise (e.g. yoga, tai chi). When trials compared more than one form of exercise, the intervention was as defined by the study author.</P>
<P>In cases in which the study author did not define the intervention, the less aerobically vigorous form of exercise was deemed the control comparator.</P>
<P>Co-interventions could include instruction in lifestyle/health education or health and exercise awareness and complementary and alternative medicine.</P>
<P>Any dosage or duration of intervention was included.</P>
<P>No restriction was placed on who delivered the intervention (i.e. researchers, primary health practitioners, physical activity professionals, health promotion agencies and medical doctors).</P>
<P>Interventions not involving exercise were excluded.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-11-12 15:47:10 +1300" MODIFIED_BY="[Empty name]">
<UL>
<LI>Vasomotor symptoms assessed by any method. Vasomotor symptoms were defined as hot flushes and/or night sweats. If more than one assessment of vasomotor symptoms was included, preference was given to the primary outcome if this was specified. If this was not specified, validated assessments were preferred over unvalidated assessments.</LI>
<LI>Individual symptoms, for example, severity or frequency, or both, of hot flushes and night sweats.</LI>
</UL>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2014-11-12 08:54:30 +1300" MODIFIED_BY="[Empty name]">
<UL>
<LI>Effectiveness: frequency or intensity of vasomotor menopausal symptoms.</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2014-11-12 15:47:10 +1300" MODIFIED_BY="[Empty name]">
<UL>
<LI>Any adverse effects of exercise interventions.</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-11-12 15:48:25 +1300" MODIFIED_BY="[Empty name]">
<P>We searched for all published and unpublished RCTs of exercise for vasomotor menopausal symptoms, without language restriction and in consultation with the Menstrual Disorders and Subfertility Group (MDSG) Trials Search Co-ordinator.</P>
<P>Searches for this review were first conducted in 2006 (between 1 and 2 June 2006). Searches for the first update of this review were conducted between 17 and 22 June 2009, and again between 16 and 24 March 2010. For this second update, searches were conducted on 3 March 2014. Searches were based on text words and index terms, when available, encompassing vasomotor symptoms, hot flushes, hot flashes, night sweats, nocturnal sweats, exercise, physical activity, physical training, yoga, tai chi, walking, running, jogging, swimming and cycling. </P>
<ELECTRONIC_SEARCHES MODIFIED="2014-11-12 15:48:25 +1300" MODIFIED_BY="[Empty name]">
<P>Searches of the following electronic bibliographic databases were performed to identify RCTs: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and PsycINFO. Science Citation Index and Social Science Citation Index, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and SPORTDiscus databases were searched for previous versions of this review, but not in this update.</P>
<P>The Cochrane Menstrual Disorders and Subfertility Group Specialised Trials Register was not searched in the first version of this review but was searched in both updates (16 March 2010 and 3 March 2014) and will be included in future updates. The search string for this register can be found in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>Search strategies can be found in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<P>Information about ongoing trials and recently completed research studies was obtained by searching Current Controlled Trials, ClinicalTrials.gov and UK Clinical Research Network Portfolio Database. A series of searches (3 March 2014) were performed using the following terms: flush, flushes, flash, flashes, sweats, sweating, nocturnal sweats, menopause.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2014-11-12 08:56:51 +1300" MODIFIED_BY="[Empty name]">
<P>Handsearches of relevant journals and published conference abstracts were performed. The following journals were handsearched: <I>Medicine and Science in Sport and Exercise</I>, <I>Maturitas</I>, <I>Menopause</I>, <I>Health Psychology</I>, <I>Journal of Women's Health</I>, <I>Women and Health</I>, <I>Obstetrics and Gynecology</I>, <I>Sports Medicine</I>, <I>British Journal of Obstetrics and Gynaecology</I> and <I>American Journal of Obstetrics and Gynecology</I>.</P>
<P>Citation lists of relevant publications, review articles and included studies were also searched.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-11-17 14:27:46 +1300" MODIFIED_BY="Helen E Nagels">
<P>Data collection and analysis were conducted in accordance with recommendations provided in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<STUDY_SELECTION MODIFIED="2014-11-17 14:27:46 +1300" MODIFIED_BY="Helen E Nagels">
<P>Marian Showell (Trials Search Co-ordinator for the Cochrane Menstrual Disorders and Subfertility Group) and review authors conducted the electronic searches for this 2014 update. Two review authors (AD, AT) independently selected reports potentially fulfilling the inclusion criteria of this review on the basis of title and abstract. Full articles of any possibly relevant reports were retrieved for more detailed evaluation. Both review authors then independently performed a final selection of trials to be included in the review by using a standardised form (eligibility form plus instruction sheet for assessing eligibility that was designed for this review). Reports were excluded according to the first criterion that they failed to fulfil. Disagreements were resolved by consensus. The principal author of the study was contacted by a review author (AD) when additional information about the trial was needed for a decision regarding the eligibility of reports.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-11-12 15:49:40 +1300" MODIFIED_BY="[Empty name]">
<P>For this 2014 update, data were independently extracted by two review authors (AD, AT) using a data extraction form designed by the review authors. When disagreements could not be resolved by consensus, a third review author (HSL) was consulted to resolve discrepancies. Additional information on trial methodology, participants and study results was sought from the first or corresponding author of some studies that appeared to meet the eligibility criteria. This occurred when aspects of methodology were unclear, when data were provided in a form unsuitable for meta-analysis or when the vasomotor symptom status of participants was unclear. When studies were followed by multiple publications, the main trial report was used as the reference and was supplemented by additional details from secondary papers.<BR/>
</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-11-12 15:50:21 +1300" MODIFIED_BY="[Empty name]">
<P>The included studies were assessed for risk of bias using the Cochrane risk of bias assessment tool to assess sequence generation; allocation concealment; blinding of participants, providers and outcome assessors; completeness of outcome data; selective outcome reporting; and other potential sources of bias. All review authors independently assessed these six domains, with disagreements resolved by consensus discussion. Results are presented in risk of bias tables for each included study.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2014-11-12 15:50:30 +1300" MODIFIED_BY="[Empty name]">
<P>For continuous data, mean differences between treatment groups were calculated if all studies reported exactly the same outcomes. If similar outcomes were reported on different scales, the standardised mean difference was used. Ordinal data were treated as continuous data.</P>
<P>A random-effects approach was used to calculate summary effect measures, as a priori it was expected that analyses would have heterogeneous results.</P>
<P>For dichotomous data, the numbers of events in the control and intervention groups of each study were used to calculate Peto odds ratios.</P>
<P>Confidence intervals (95%) were presented for all outcomes and comparisons.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2014-11-12 09:08:56 +1300" MODIFIED_BY="[Empty name]">
<P>We planned to include all cluster-randomised trials in the analyses, along with individually randomised trials. We adjusted sample sizes or standard errors using the methods set out in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). If both cluster-randomised trials and individually randomised trials were included, we planned to synthesise relevant information. We considered it reasonable to combine the results from both when little heterogeneity was noted between study designs, and when interaction between effects of the intervention and choice of the randomisation unit was considered unlikely.</P>
<P>In cross-over trials, we planned to include only data from the first phase in the meta-analysis. <BR/>
</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2014-11-12 09:09:05 +1300" MODIFIED_BY="[Empty name]">
<P>As far as possible, data were reported using an intention-to-treat analysis, and attempts were made to obtain missing data from the original investigators.<BR/>
</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-11-12 15:51:06 +1300" MODIFIED_BY="[Empty name]">
<P>Heterogeneity was considered by the review authors when clinical and methodological characteristics of included studies were similar enough for a meta-analysis to yield a meaningful summary. Statistical analyses were performed in accordance with the guidelines for statistical analysis developed by The Cochrane Collaboration (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Heterogeneity between the results of different studies was assessed by the I<SUP>2</SUP> statistic (a quantity that describes approximately the proportion of variation in point estimates that is due to heterogeneity rather than sampling error), which can be interpreted in these broad terms.</P>
<UL>
<LI>0% to 40%: might not be important.</LI>
<LI>30% to 60%: represents moderate heterogeneity.</LI>
<LI>50% to 90%: represents substantial heterogeneity.</LI>
<LI>75% to 100%: represents considerable heterogeneity (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</LI>
</UL>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2014-11-12 09:11:42 +1300" MODIFIED_BY="[Empty name]">
<P>The review authors aimed to minimise the potential impact of reporting bias by ensuring a comprehensive search for eligible studies and by staying alert for duplication of data. It was planned that a funnel plot would be prepared if 10 or more studies were identified. However, too few studies were identified for construction of a funnel plot.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-11-12 09:12:10 +1300" MODIFIED_BY="[Empty name]">
<P>When possible, data from included studies were combined using random-effects models in the following comparisons.</P>
<UL>
<LI>Exercise versus inactive control.</LI>
<LI>Exercise versus yoga.</LI>
<LI>Exercise versus HT.</LI>
</UL>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2014-11-12 09:13:00 +1300" MODIFIED_BY="[Empty name]">
<P>Data permitting, subgroup analyses were performed to determine separate evidence for the following.</P>
<UL>
<LI>Perimenopausal women.</LI>
<LI>Postmenopausal women.</LI>
<LI>Different co-interventions.</LI>
<LI>Intervention duration (up to 6 months vs 6 months or longer).</LI>
</UL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2014-11-12 15:52:40 +1300" MODIFIED_BY="[Empty name]">
<P>We conducted a sensitivity analysis for the primary outcomes to determine whether review conclusions would have differed if eligibility were restricted to studies at low risk of bias (i.e. studies not deemed at high risk of bias in any domain and reporting acceptable methods of randomisation and allocation concealment).</P>
<SUBSECTION>
<HEADING LEVEL="3">Overall quality of the body of evidence: 'Summary of findings' table</HEADING>
<P>We prepared a 'Summary of findings' table using Guideline Development Tool software. This table evaluated the overall quality of the body of evidence for the primary review outcome using GRADE (Grades of Recommendation, Assessment, Development and Evaluation) criteria (study limitations (i.e. risk of bias), consistency of effect, imprecision, indirectness and publication bias).</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-11-24 11:51:30 +1300" MODIFIED_BY="Helen E Nagels">
<STUDY_DESCRIPTION MODIFIED="2014-11-24 11:51:30 +1300" MODIFIED_BY="Helen E Nagels">
<SEARCH_RESULTS MODIFIED="2014-11-12 15:53:39 +1300" MODIFIED_BY="[Empty name]">
<P>In the 2007 version of this review, through a comprehensive literature search, 655 potentially relevant references were identified and screened for retrieval. A total of 603 references were excluded on the basis of title and abstract, and 52 references were retrieved for more detailed evaluation. Of these, and after further scrutiny, 33 publications were not considered suitable for inclusion in the review, as they were commentaries, observational studies or reviews, and 18 publications initially considered eligible on the basis of information contained in the abstract were subsequently excluded after the full study report had been evaluated (see below). Thus, one study (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>) was eligible for inclusion in the 2007 version of this review (see <LINK TAG="INCLUDED_STUDIES_DESCR" TYPE="SECTION">Included studies</LINK> section below).</P>
<P>For the first update of the review (2011), a further 557 potentially relevant references were identified and screened for retrieval. A total of 513 references were excluded on the basis of title and abstract, and 44 references were retrieved for more detailed evaluation. Of these, and after further scrutiny, 24 publications were not considered suitable for inclusion in the review, as they were commentaries, observational studies or reviews, and 12 publications initially considered eligible on the basis of information contained in the abstract were subsequently excluded after the full study report had been evaluated (see below). Thus an additional eight reports (five studies: <LINK REF="STD-Bergstr_x00f6_m-2005" TYPE="STUDY">Bergström 2005</LINK>; <LINK REF="STD-Chatta-2008" TYPE="STUDY">Chatta 2008</LINK>; <LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>; <LINK REF="STD-Moriyama-2008" TYPE="STUDY">Moriyama 2008</LINK>) were identified as eligible, meaning that a grand total of six studies (nine reports) were eligible for inclusion.</P>
<P>For this second update of the review (2014), a further 1878 potentially relevant references were identified by the searches, and 27 were screened for retrieval. A total of nine references were excluded on the basis of title and abstract, and 18 references were retrieved for more detailed evaluation. Of these, and after further scrutiny, two publications were not considered suitable for inclusion in the review, as they were commentaries, observational studies or reviews, and 14 publications initially considered eligible on the basis of information contained in the abstract were subsequently excluded after the full study report had been evaluated (see below). Therefore two studies were eligible for inclusion (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>). For details of study screening and selection, see <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-11-24 11:51:30 +1300" MODIFIED_BY="Helen E Nagels">
<P>In this second update of the review (2014), on the advice of the Cochrane Review Group and peer reviewers, three previously included studies (<LINK REF="STD-Bergstr_x00f6_m-2005" TYPE="STUDY">Bergström 2005</LINK>; <LINK REF="STD-Chatta-2008" TYPE="STUDY">Chatta 2008</LINK>; <LINK REF="STD-Moriyama-2008" TYPE="STUDY">Moriyama 2008</LINK>) have been excluded from further updates. Whilst the authors of these three studies had provided data on women who were symptomatic at baseline, it was believed important for future updates to adhere to clear criteria of including only studies in which all women were symptomatic at baseline.</P>
<P>Therefore a grand total of five studies (nine reports) were eligible for inclusion in this 2014 update (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>; <LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>). The <LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK> study has one additional report (Elavsky 2009), the <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK> study has two additional reports (Mannsikkamaki 2012; Moilanen 2012) and the <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK> study has one additional report (Newton 2013) relevant to this review. Full descriptions of the included studies can be found under <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>
<B>Study design</B>
</P>
<P>All included trials were parallel-group randomised controlled trials (RCTs). They took place in Iran (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>), Sweden (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>), USA (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>) and Finland (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>). All studies appeared to be single-centre, except one (<LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>).</P>
<P>Use of intention-to-treat analysis was clearly specified in three trials (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>). </P>
<P>Two studies stated that power calculations were used to statistically estimate the sample size (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>). </P>
<P>
<B>Participants</B>
</P>
<P>The five included studies randomly assigned a total of 762 perimenopausal or postmenopausal women. Four trials (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>; <LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>) determined menopausal status by measuring serum follicle-stimulating hormone levels and serum oestradiol levels. One trial determined menopausal status by examining self-reported bleeding patterns (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>). This trial reported that premenopausal women were also included in the sample (n = 17%), as determined by self-reported bleeding patterns. However, contact with study authors revealed that the bleeding history of women who initially reported no signs of the menopause transition based on bleeding criteria was verified before their entry into the trial (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>). All trials required that women were not using any hormone treatment (HT) at baseline.</P>
<P>All studies included only participants who were vasomotor symptomatic at baseline. Only two trials specified the length of time participants had been experiencing vasomotor symptoms before baseline. One trial (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>) recruited women who had been experiencing vasomotor symptoms in the last month before baseline, and another (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>) recruited participants who had been vasomotor symptomatic for at least six months previously. In one trial (<LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>), the frequency and bothersomeness of participants' vasomotor symptoms were measured before randomisation.</P>
<P>Four studies included women who were sedentary or had low activity at baseline (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>). One study excluded women who had been practicing yoga before baseline (<LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>). One study did not state the baseline exercise levels of participants (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>). </P>
<P>In three trials (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>), participants were recruited after they responded to newspaper advertisements or to other media. One trial (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>) recruited participants through a combination of newspaper advertisements and via gynaecology outpatient clinics. One study did not report the method used to recruit participants (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>). </P>
<P>Four trials (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>) reported generally comparable group demographic characteristics at baseline. One trial (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>) did not report the demographic characteristics of groups at baseline.</P>
<P>
<B>Interventions</B>
</P>
<P>Comparisons were as follows.</P>
<UL>
<LI>Exercise (walking) versus yoga versus no intervention (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>).</LI>
<LI>Exercise (aerobics) versus HT (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>).</LI>
<LI>Exercise (walking) plus soy milk consumption versus soy milk consumption only versus no intervention (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>).</LI>
<LI>Exercise (cardiovascular conditioning) versus yoga versus usual activity, plus omega-3 or placebo pills in a 1:1 ratio within each group (<LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>).</LI>
<LI>Exercise (walking) versus controls, plus lectures once or twice per month on physical activity and general health in both arms (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>).</LI>
</UL>
<P>Length of the interventions ranged from three (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>; <LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>) to four (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>) to six months (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>). Only two trials provided data on compliance with the intervention(s) (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>).</P>
<P>
<B>Outcomes</B>
</P>
<P>
<I>
<B>Vasomotor symptoms</B>
</I>
</P>
<P>All studies assessed vasomotor symptoms by self-report. One trial (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>) assessed vasomotor symptoms by using more than one questionnaire/measure, but only one of the measures had been validated (the vasomotor symptoms subscale of the Women's Health Questionnaire). One study (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>) used the Greene Climacteric Scale (<LINK REF="REF-Greene-1998" TYPE="REFERENCE">Greene 1998</LINK>). Two studies (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>; <LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>) used the Kupperman Index (<LINK REF="REF-Kupperman-1959" TYPE="REFERENCE">Kupperman 1959</LINK>), although one study (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>) did not report data specifically from the vasomotor symptoms subscale. Two studies (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>) used a log/diary to assess the number and/or severity of hot flushes at baseline and at follow-up.</P>
<P>
<B>Adverse events</B>
</P>
<P>One study (<LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>) assessed adverse events.</P>
<P>
<B>Data extraction</B>
</P>
<P>Data from all trials, except one (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>), were entered into the meta-analysis. One study produced binary data (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>), and four studies produced continuous data (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>). One study included both continuous (primary outcome) and binary data (secondary outcome). In the meta-analyses, we used data from the final follow-up, regardless of time since baseline. </P>
<P>Length of follow-up varied considerably between studies, ranging from three months (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>) to six months (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>) to nine months (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>) to 24 months (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>).</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-11-12 16:01:42 +1300" MODIFIED_BY="[Empty name]">
<P>In 2007, on the basis of information provided in the abstract, one study was not traceable by the British Library (<LINK REF="STD-Pangaotopulos-2004" TYPE="STUDY">Pangaotopulos 2004</LINK>) despite numerous search attempts. Eight reports were not RCTs (<LINK REF="STD-Hammar-1990" TYPE="STUDY">Hammar 1990</LINK>; <LINK REF="STD-Kemmler-2004" TYPE="STUDY">Kemmler 2004</LINK>; <LINK REF="STD-Salmone-1998" TYPE="STUDY">Salmone 1998</LINK>; <LINK REF="STD-Slaven-1994" TYPE="STUDY">Slaven 1994</LINK>; <LINK REF="STD-Wallace-1982" TYPE="STUDY">Wallace 1982</LINK>; <LINK REF="STD-Weltman-1982" TYPE="STUDY">Weltman 1982</LINK>; <LINK REF="STD-Ueda-2000" TYPE="STUDY">Ueda 2000</LINK>; <LINK REF="STD-Ueda-2004" TYPE="STUDY">Ueda 2004</LINK>). Eight reports did not include women who were symptomatic at baseline (<LINK REF="STD-Aiello-2004" TYPE="STUDY">Aiello 2004</LINK>; <LINK REF="STD-Boraz-2001" TYPE="STUDY">Boraz 2001</LINK>; <LINK REF="STD-Hunter-1999" TYPE="STUDY">Hunter 1999</LINK>; <LINK REF="STD-Krasnoff-1996" TYPE="STUDY">Krasnoff 1996</LINK>; <LINK REF="STD-Liao-1998" TYPE="STUDY">Liao 1998</LINK>; <LINK REF="STD-Polis-1989" TYPE="STUDY">Polis 1989</LINK>; <LINK REF="STD-Steele-1997" TYPE="STUDY">Steele 1997</LINK>; <LINK REF="STD-Wilbur-2005" TYPE="STUDY">Wilbur 2005</LINK>); we were unable to obtain data for women in these trials who were symptomatic, and we were unable to reach the trial authors or the authors were unable to provide data in a usable form for this review. For further details, see the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> tables.</P>
<P>Further studies were identified as ineligible during the process of updating the 2011 review (first update). Five reports were not RCTs (<LINK REF="STD-Booth_x002d_LaForce-2007" TYPE="STUDY">Booth-LaForce 2007</LINK>; <LINK REF="STD-Cohen-2006" TYPE="STUDY">Cohen 2006</LINK>; <LINK REF="STD-Elavsky-2005" TYPE="STUDY">Elavsky 2005</LINK>; <LINK REF="STD-Lee-2009" TYPE="STUDY">Lee 2009</LINK>; <LINK REF="STD-McAndrew-2009" TYPE="STUDY">McAndrew 2009</LINK>), four reports did not include vasomotor symptomatic women at baseline (<LINK REF="STD-Asbury-2006" TYPE="STUDY">Asbury 2006</LINK>; <LINK REF="STD-Gonzalez-2009" TYPE="STUDY">Gonzalez 2009</LINK>; <LINK REF="STD-Maesta--2007" TYPE="STUDY">Maesta 2007</LINK>; <LINK REF="STD-Villaverde-2006b" TYPE="STUDY">Villaverde 2006b</LINK>), one report did not include an exercise intervention (<LINK REF="STD-Welty-2007" TYPE="STUDY">Welty 2007</LINK>) and one report did not include a measure of vasomotor symptoms (<LINK REF="STD-O_x0027_Donnell-2009" TYPE="STUDY">O'Donnell 2009</LINK>).</P>
<P>In this 2014 update of the review, a further 15 studies were retrieved and excluded for the following reasons: duplicate abstract of another study (<LINK REF="STD-Cramer-2012b" TYPE="STUDY">Cramer 2012b</LINK>); no measure of vasomotor symptoms (<LINK REF="STD-Foster_x002d_Schubert-2012" TYPE="STUDY">Foster-Schubert 2012</LINK>; <LINK REF="STD-Kline-2012" TYPE="STUDY">Kline 2012</LINK>; <LINK REF="STD-Kok-2005" TYPE="STUDY">Kok 2005</LINK>; <LINK REF="STD-Lee-2012" TYPE="STUDY">Lee 2012</LINK>; <LINK REF="STD-Riesco-2012" TYPE="STUDY">Riesco 2012</LINK>; <LINK REF="STD-Villaverde_x002d_Guti_x00e9_rrez-2012" TYPE="STUDY">Villaverde-Gutiérrez 2012</LINK>); unclear whether participants were vasomotor symptomatic at baseline (<LINK REF="STD-Llaneza-2011" TYPE="STUDY">Llaneza 2011</LINK>; <LINK REF="STD-Riesco-2011" TYPE="STUDY">Riesco 2011</LINK>); participants were not vasomotor symptomatic at baseline (<LINK REF="STD-Alfonso-2012" TYPE="STUDY">Alfonso 2012</LINK>; <LINK REF="STD-Joshi-2011" TYPE="STUDY">Joshi 2011</LINK>; <LINK REF="STD-Ogwumike-2011" TYPE="STUDY">Ogwumike 2011</LINK>); trials were not RCTs (<LINK REF="STD-Garcia-2011" TYPE="STUDY">Garcia 2011</LINK>); and participants were taking HT at baseline (<LINK REF="STD-Huang-2010" TYPE="STUDY">Huang 2010</LINK>; <LINK REF="STD-Moreira-2012" TYPE="STUDY">Moreira 2012</LINK>). As discussed earlier, in this second update of the review (2014), it was decided that the studies by <LINK REF="STD-Bergstr_x00f6_m-2005" TYPE="STUDY">Bergström 2005,</LINK> <LINK REF="STD-Chatta-2008" TYPE="STUDY">Chatta 2008</LINK> and <LINK REF="STD-Moriyama-2008" TYPE="STUDY">Moriyama 2008</LINK> that had been included in the 2010 review should be excluded from any subsequent updates, including this one, as not all randomly assigned participants were symptomatic at baseline.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-11-12 16:03:54 +1300" MODIFIED_BY="[Empty name]">
<P>For further details, refer to the methodological quality summary (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>) and the methodological quality graph (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
<ALLOCATION MODIFIED="2014-11-12 16:02:49 +1300" MODIFIED_BY="[Empty name]">
<P>Three studies reported adequate methods of sequence generation (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>). They used computer-generated lists. Two trials did not specify this information and were rated as having unclear risk in this domain (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>; <LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>).</P>
<P>Two studies provided evidence of adequate allocation concealment (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>); presealed envelopes, identical opaque sealed envelopes or a secure Web-based database was used. Two studies provided insufficient information as to whether allocation was concealed and were rated as having unclear risk in this domain (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>). Contact with the trial authors revealed that allocation was not concealed in one trial (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>); this study was rated as having high risk of bias in this domain.</P>
</ALLOCATION>
<BLINDING MODIFIED="2014-11-12 16:03:13 +1300" MODIFIED_BY="[Empty name]">
<P>Evaluation of exercise-based treatment is more difficult than evaluation of other types of treatment such as pharmacological interventions because usually neither the participant nor the intervener can be blinded to participants' allocation; comments here should be interpreted in light of these constraints. Two trials clearly stated that outcome assessors were blinded to group allocation and were rated as having low risk of bias in this domain (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>). The other studies were rated as having unclear risk of bias.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-11-12 16:03:54 +1300" MODIFIED_BY="[Empty name]">
<P>Two trials adequately addressed this domain and were rated as having low risk of bias (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>). One trial had a high attrition rate and was rated as having high risk of bias (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>), and in two trials, the risk of bias was unclear (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>). Please see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> for details.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2014-11-12 09:43:49 +1300" MODIFIED_BY="[Empty name]">
<P>Only one trial reported adverse events (<LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>) and was rated as having low risk of bias in this domain. The other studies were rated as having unclear risk of selective reporting bias.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2014-11-12 09:44:26 +1300" MODIFIED_BY="[Empty name]">
<P>No other potential source of bias was identified for two trials (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>), which were rated as having low risk in this domain. Three trials were rated as having unclear risk of bias in this domain as a result of lack of baseline equivalence between groups (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>), poor reporting (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>) or high rates of cross-over between treatment arms (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-11-17 14:24:19 +1300" MODIFIED_BY="Helen E Nagels">
<P>Three meta-analyses were conducted: exercise versus no treatment/control, exercise versus yoga and exercise versus HT. In the five included studies, a total of 762 participants were randomly assigned, but data from one study (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>) (n = 37) could not be included in any meta-analysis. Therefore data from 725 randomly assigned participants were eligible for inclusion in the meta-analyses, and of these, 605 provided follow-up data (83.4%).</P>
<SUBSECTION>
<HEADING LEVEL="3">1 Exercise versus no treatment/control</HEADING>
<P>Four trials were eligible for inclusion in the comparison of exercise versus no treatment or a control condition.</P>
<P>Three studies compared exercise (walking (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>), aerobic exercise (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>) and cardiovascular training (<LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>)) versus no intervention. A fourth study (<LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK>) compared exercise plus soy milk versus soy milk alone or a control condition (not described). No direct comparison was performed between the two intervention groups.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.1 Frequency or intensity of vasomotor menopausal symptoms</HEADING>
<P>When three studies were pooled (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>; <LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>), no evidence suggested a difference between groups (standardised mean difference (SMD) -0.10, 95% confidence interval (CI) -0.33 to 0.13, 454 participants, I<SUP>2 </SUP>= 30%, low-quality evidence) (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4;</LINK> <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). <LINK REF="STD-Hanachi-2008" TYPE="STUDY">Hanachi 2008</LINK> reported data unsuitable for pooling. Thirty-seven women were included in the analysis. The study authors stated that hot flush scores decreased significantly during the treatment period in the exercise plus soy milk group and in the soy milk only group, relative to the control group (P value &lt; 0.05). See <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK> for details.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.2 Adverse effects of the intervention</HEADING>
<P>The number of incident adverse events was reported in one trial (<LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>) and was similar in both groups (17% for exercise and 18% for usual activity); no serious adverse events related to the study occurred in either group.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2 Exercise versus yoga</HEADING>
<P>Two studies were included in this analysis (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5;</LINK> <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). These trials compared exercise (walking) (<LINK REF="STD-Elavsky-2007" TYPE="STUDY">Elavsky 2007</LINK>) and cardiovascular training (<LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>) versus yoga.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.1 Frequency or intensity of vasomotor menopausal symptoms</HEADING>
<P>When the two studies were pooled, no evidence showed a difference between groups (SMD 0.03, 95% CI -0.45 to 0.38, 279 participants, I<SUP>2 </SUP>= 61%, low-quality evidence).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.2 Adverse effects of the intervention</HEADING>
<P>No serious adverse events were reported for either group.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">3 Exercise versus hormone therapy (HT)</HEADING>
<P>One trial compared exercise (aerobics) versus HT (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Frequency or intensity of vasomotor menopausal symptoms</HEADING>
<P>In this trial (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>) at 12 weeks' follow-up, a larger reduction in frequency of hot flushes per 24 hours was seen in the HT group than in the exercise group (mean difference 5.80, 95% CI 3.17 to 8.43, 14 participants) (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>; <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.2 Adverse effects of the intervention</HEADING>
<P>Data on adverse effects of the intervention were not reported in the only trial included in this comparison.</P>
<P>
<B>Sensitivity analyses</B>
</P>
<P>Only one study was deemed to have low risk of bias (<LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>). Exclusion from analysis of other studies did not affect our overall findings for any outcome.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-11-12 16:07:29 +1300" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2014-11-12 16:06:43 +1300" MODIFIED_BY="[Empty name]">
<P>Evidence was insufficient to show whether exercise is an effective treatment for vasomotor menopausal symptoms. Evidence was also insufficient to reveal the relative effectiveness of exercise when compared with HT or yoga. The evidence was of low quality because of observed limitations in study design, inconsistency and imprecision.</P>
<P>The two largest trials to date (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>; <LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>) showed no significant differences between exercise and control groups for their primary outcome of vasomotor symptoms. These results should also be considered in the context of intervention contamination, which is often a problem with exercise trials, as comparator/usual care groups may spontaneously choose to exercise, thereby diluting the effect. This issue might have been a particular problem in one of the larger included trials (<LINK REF="STD-Luoto-2012" TYPE="STUDY">Luoto 2012</LINK>), in which the control group was given lectures on physical activity, thus providing encouragement for them to exercise. Although the RCOG (<LINK REF="REF-RCOG-2006" TYPE="REFERENCE">RCOG 2006</LINK>) has advised that regular aerobic exercise may help relieve menopausal symptoms, the most common of which is hot flushes, current evidence does not support this statement. Additional high-quality trials are required before conclusions can be drawn about the effectiveness of exercise compared with no treatment or active interventions such as yoga or HT. Evidence of heterogeneity is also apparent in the meta-analysis of exercise versus yoga, highlighting further the need for additional research.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-11-12 09:56:33 +1300" MODIFIED_BY="[Empty name]">
<P>Data regarding adverse effects of exercise interventions are insufficient, and not all studies reported data in a form that could be included in the meta-analysis.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-11-12 16:07:29 +1300" MODIFIED_BY="[Empty name]">
<P>The methodological quality of studies was variable, and only one trial (<LINK REF="STD-Sternfeld-2014" TYPE="STUDY">Sternfeld 2014</LINK>) was at low risk of bias. In the comparisons of exercise versus control/no treatment, 30% heterogeneity was evident, whereas in the comparison of exercise versus yoga, heterogeneity was high (61%), possibly because of differences between studies in intensity of the interventions.</P>
<P>Sample sizes in both meta-analyses were relatively small. Some study authors did not follow the CONSORT (Consolidated Standards of Reporting Trials) guidelines in reporting their studies; this often made it difficult for review authors to extract and interpret the information required for this review. Studies also varied considerably by type and duration of the exercise intervention and length of follow-up.</P>
<P>We assessed the evidence as low quality: Limitations in study design, inconsistency and imprecision were noted. Methods of recruitment and of determining menopausal status varied, as did characteristics of included women. Evidence was self-reported on a variety of validated scales or logs/diaries. Both meta-analyses showed variation in the direction of effect.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2014-11-12 10:22:45 +1300" MODIFIED_BY="[Empty name]">
<P>Publication and selection biases are potential threats to all systematic reviews. We believe that all relevant studies have been identified but cannot rule out the possibility that additional trials may be unpublished or published in sources not accessible to our search.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2014-06-05 22:56:08 +1200" MODIFIED_BY="[Empty name]">
<P>We are not aware of any other published reviews of randomised controlled trials that have assessed the effectiveness of exercise as a treatment for vasomotor menopausal symptoms.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-11-12 16:08:10 +1300" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2014-11-12 10:23:39 +1300" MODIFIED_BY="[Empty name]">
<P>Evidence was insufficient to show whether exercise is an effective treatment for vasomotor menopausal symptoms. Evidence was also insufficient to reveal the relative effectiveness of exercise and yoga. One small study suggested that HT is more effective than exercise.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-11-12 16:08:10 +1300" MODIFIED_BY="[Empty name]">
<P>Additional high-quality trials of exercise versus no exercise or in comparison with other types of interventions would be welcome. Studies should evaluate not just the outcomes of frequency and intensity of vasomotor symptoms, but also whether adverse events are associated with exercise. Cost/benefit analyses should be included. Adherence has not been detailed in reports or has not been reported in sufficient detail to show how much exercise women were performing throughout the interventions. Future trials should measure and report adherence in greater detail.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-11-12 11:38:47 +1300" MODIFIED_BY="[Empty name]">
<P>We are grateful for the help of Ann Fry-Smith in conducting the electronic searches. We thank A McTiernan, M Hammar, M Ueda and JE Wilbur for responding to queries in previous versions of this review. We also thank I Bergstrom, R Chatta, S Elavsky and C Moriyama for providing data and for responding to queries related to the second update (2011) of this review. We thank Barbara Sternfeld for responding to queries in this third update (2014) of the review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2014-11-12 11:40:57 +1300" MODIFIED_BY="[Empty name]">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2014-11-12 16:09:08 +1300" MODIFIED_BY="[Empty name]">
<P>
<B>Amanda Daley: </B>conceived of the review, co-ordinated the review, collected and managed data for the review, read the final draft and served as guarantor of the review.</P>
<P>
<B>Helen Stokes-Lampard: </B>collected and managed data for the review and read and commented on the final draft.</P>
<P>
<B>Chrstine MacArthur: </B>collected data for the review and read and commented on the final draft.</P>
<P>
<B>Adèle Thomas: </B>collected data for the review and read and commented on the final draft</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2014-11-12 11:41:13 +1300" MODIFIED_BY="[Empty name]">
<P>The secondary outcomes of quality of life, tolerability and general symptomatology have been deleted and are no longer included in this review.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2014-03-26 04:04:22 +1300" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-11-24 11:50:26 +1300" MODIFIED_BY="Helen E Nagels">
<STUDIES MODIFIED="2014-11-12 14:02:14 +1300" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2014-11-12 13:46:24 +1300" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Elavsky-2007" MODIFIED="2014-11-12 13:43:08 +1300" MODIFIED_BY="[Empty name]" NAME="Elavsky 2007" YEAR="2009">
<REFERENCE MODIFIED="2014-11-12 13:42:56 +1300" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Elavsky S, McAuley E</AU>
<TI>Physical activity and mental health outcomes during menopause: a randomised controlled trial.</TI>
<SO>Annals of Behavioral Medicine</SO>
<YR>2007</YR>
<VL>33</VL>
<PG>132-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-11-12 13:43:08 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elavsky S</AU>
<TI>Physical activity, menopause, and quality of life: the role of affect and self-worth across time</TI>
<SO>Menopause</SO>
<YR>2009</YR>
<VL>16</VL>
<NO>2</NO>
<PG>265-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-01-23 04:26:42 +1300" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Hanachi-2008" MODIFIED="2014-11-12 13:43:28 +1300" MODIFIED_BY="[Empty name]" NAME="Hanachi 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-11-12 13:43:28 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hanachi P, Golkho S</AU>
<TI>Assessment of soy phytoestrogens and exercise on lipid profiles and menopause symptoms in menopausal women</TI>
<SO>Journal of Biological Sciences</SO>
<YR>2008</YR>
<VL>8</VL>
<NO>4</NO>
<PG>789-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindh_x002d__x00c5_strand-2004" MODIFIED="2014-11-12 13:44:13 +1300" MODIFIED_BY="[Empty name]" NAME="Lindh-Åstrand 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-11-12 13:44:13 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindh-Åstrand L, Nedstrand E, Wyon Y, et al</AU>
<TI>Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy</TI>
<SO>Maturitas</SO>
<YR>2004</YR>
<VL>48</VL>
<PG>97-105</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luoto-2012" MODIFIED="2014-11-12 13:45:54 +1300" MODIFIED_BY="[Empty name]" NAME="Luoto 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-12 13:45:09 +1300" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Luoto R, Moilanen J, Heinonen R, et al</AU>
<TI>Effect of aerobic training on hot flushes and quality of life&#8212;a randomized controlled trial</TI>
<SO>Annals of Medicine</SO>
<YR>2012</YR>
<VL>44</VL>
<PG>616-26</PG>
<IDENTIFIERS MODIFIED="2014-04-02 01:32:53 +1300" MODIFIED_BY="Amanda Daley"/>
</REFERENCE>
<REFERENCE MODIFIED="2014-11-12 13:45:35 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mannsikkamaki K, Raitanen J, Nygard C, et al</AU>
<TI>Sleep quality and aerobic training among menopausal women&#8212;a randomized controlled trial</TI>
<SO>Maturitas</SO>
<YR>2012</YR>
<VL>72</VL>
<PG>339-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-11-12 13:45:54 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moilanen J, Mikkola T, Raitanen J, et al</AU>
<TI>Effect of aerobic training on menopausal symptoms&#8212;a randomized controlled trial</TI>
<SO>Menopause</SO>
<YR>2012</YR>
<VL>19</VL>
<PG>691-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-10-16 14:14:12 +1300" MODIFIED_BY="Amanda Daley"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sternfeld-2014" MODIFIED="2014-11-12 13:46:24 +1300" MODIFIED_BY="[Empty name]" NAME="Sternfeld 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-11-12 13:46:12 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Newton M, Reed S, Guthrie KA, et al</AU>
<TI>Efficacy of yoga for vasomotor symptoms: a randomised controlled trial</TI>
<SO>Menopause</SO>
<YR>2014</YR>
<VL>21</VL>
<NO>4</NO>
<PG>339-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-11-12 13:46:24 +1300" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sternfeld B, Guthrie KA, Ensrud EE, et al</AU>
<TI>Efficacy of exercise for menopausal symptoms: a randomized controlled trial</TI>
<SO>Menopause</SO>
<YR>2014</YR>
<VL>21</VL>
<NO>4</NO>
<PG>330-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-07-09 01:33:53 +1200" MODIFIED_BY="Amanda Daley"/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-11-12 14:01:53 +1300" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Aiello-2004" NAME="Aiello 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aiello EJ, Yasui Y, Tworoger A, et al</AU>
<TI>Effect of a yearlong moderate-intensity exercise intervention on the occurrence and severity of menopausal symptoms in post-menopausal women</TI>
<SO>Menopause</SO>
<YR>2004</YR>
<VL>11</VL>
<PG>382-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alfonso-2012" MODIFIED="2014-11-12 13:46:46 +1300" MODIFIED_BY="[Empty name]" NAME="Alfonso 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-12 13:46:46 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alfonso RF, Hachul H, Kozasa EH</AU>
<TI>Yoga decreases insomnia in postmenopausal women: a randomized clinical trial</TI>
<SO>Menopause</SO>
<YR>2012</YR>
<VL>2</VL>
<PG>186-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Asbury-2006" MODIFIED="2014-11-12 13:47:01 +1300" MODIFIED_BY="[Empty name]" NAME="Asbury 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-11-12 13:47:01 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Asbury EA, Chandttuangphen P, Collins P</AU>
<TI>The importance of continued exercise participation in quality of life and psychological well-being in previously inactive postmenopausal women: a pilot study</TI>
<SO>Menopause</SO>
<YR>2006</YR>
<VL>13</VL>
<PG>561-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Bergstr_x00f6_m-2005" MODIFIED="2014-11-12 13:47:30 +1300" MODIFIED_BY="[Empty name]" NAME="Bergström 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-11-12 13:47:15 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bergström I, Freyschuss B, Landgren BM</AU>
<TI>Physical training and hormone replacement therapy reduce the decrease in bone mineral density in perimenopausal women: a pilot study</TI>
<SO>Osteporosis International</SO>
<YR>2005</YR>
<VL>16</VL>
<PG>823-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-11-12 13:47:30 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bergström I, Landgren BM, Pyykkö I</AU>
<TI>Training or EPT in perimenopause on balance and flushes</TI>
<SO>Acta Obstetricia et Gynecologica</SO>
<YR>2007</YR>
<VL>86</VL>
<PG>467-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Booth_x002d_LaForce-2007" MODIFIED="2010-03-29 10:28:41 +1300" MODIFIED_BY="jane clarke" NAME="Booth-LaForce 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-03-29 10:28:41 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Booth-LaForce C, Thurston RC, Taylor MR</AU>
<TI>A pilot study of a Hatha yoga treatment for menopausal symptoms</TI>
<SO>Maturitas</SO>
<YR>2007</YR>
<VL>57</VL>
<PG>286-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boraz-2001" MODIFIED="2014-11-12 13:47:51 +1300" MODIFIED_BY="[Empty name]" NAME="Boraz 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-11-12 13:47:51 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boraz MA, Simkin-Silverman, LR, Wing RR, et al</AU>
<TI>Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention</TI>
<SO>Preventive Medicine</SO>
<YR>2001</YR>
<VL>33</VL>
<PG>108-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Chatta-2008" MODIFIED="2014-03-26 04:16:30 +1300" MODIFIED_BY="Amanda Daley" NAME="Chatta 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-03-26 04:14:46 +1300" MODIFIED_BY="Amanda Daley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chatta R, Nagarathna R, Padmalatha V, et al</AU>
<TI>Treating the climacteric symptoms in Indian women with an integrated approach to yoga therapy: a randomised control study</TI>
<SO>Menopause</SO>
<YR>2008</YR>
<VL>15</VL>
<PG>862-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-26 04:16:30 +1300" MODIFIED_BY="Amanda Daley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chatta R, Nagarathna R, Padmalatha V</AU>
<TI>Effect of yoga on cognitive functions in climacteric syndrome: a randomised control study</TI>
<SO>BJOG</SO>
<YR>2008</YR>
<VL>115</VL>
<PG>991-1000</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cohen-2006" MODIFIED="2010-02-03 03:24:49 +1300" MODIFIED_BY="[Empty name]" NAME="Cohen 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-02-03 03:24:28 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cohen BE, Kanaya AM, Macer JL, et al</AU>
<TI>Feasibility and acceptability of restorative yoga for treatment of hot flushes: a pilot trial</TI>
<SO>Maturitas</SO>
<YR>2007</YR>
<VL>56</VL>
<PG>198-204</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cramer-2012b" MODIFIED="2014-11-12 13:48:56 +1300" MODIFIED_BY="[Empty name]" NAME="Cramer 2012b" YEAR="2012b">
<REFERENCE MODIFIED="2014-11-12 13:48:28 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cramer H, Lauche R, Langhorst J, et al</AU>
<TI>Efficacy of yoga and of mindfulness-based stress reduction for menopausal symptoms&#8212;systematic reviews and meta-analyses</TI>
<SO>Evidenced-Based Complementary and Alternative Medicine</SO>
<YR>2012</YR>
<VL>Article ID 863905</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-11-12 13:48:56 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cramer H, Romy L, Langhorst J, et al</AU>
<TI>Efficacy of yoga of mindfulness-based stress reduction for menopausal symptoms-systematic review and meta analysis</TI>
<SO>European Journal of Integrative Medicine</SO>
<YR>2012</YR>
<VL>4S</VL>
<PG>124-301</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elavsky-2005" MODIFIED="2014-08-20 22:14:23 +1200" MODIFIED_BY="Helen E Nagels" NAME="Elavsky 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-03-29 10:28:52 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elvasky S, McAuley E</AU>
<TI>Physical activity, symptoms, esteem and life satisfaction during menopause</TI>
<SO>Maturitas</SO>
<YR>2005</YR>
<VL>52</VL>
<PG>374-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Foster_x002d_Schubert-2012" MODIFIED="2014-11-12 13:49:12 +1300" MODIFIED_BY="[Empty name]" NAME="Foster-Schubert 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-12 13:49:12 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Foster-Schubert KE, Alfano CM, Xiao L, et al</AU>
<TI>Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese post-menopausal women</TI>
<SO>Obesity</SO>
<YR>2012</YR>
<VL>20</VL>
<PG>1628-38</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garcia-2011" MODIFIED="2014-11-12 13:50:26 +1300" MODIFIED_BY="[Empty name]" NAME="Garcia 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-11-12 13:50:26 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia CL, Gómez-Calcerrada SG</AU>
<TI>Cognitive-behavioral intervention among women with slight menopausal symptoms: a pilot study</TI>
<SO>Spanish Journal of Psychology</SO>
<YR>2011</YR>
<VL>1</VL>
<PG>344-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gonzalez-2009" MODIFIED="2014-11-12 13:50:37 +1300" MODIFIED_BY="[Empty name]" NAME="Gonzalez 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-11-12 13:50:37 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gonzalez G, Garcia F, Rubio B, et al</AU>
<TI>An ambulatory physical exercise program improves in the short term weight and quality of life of obese post-menopausal women</TI>
<SO>Medicina Cliinica</SO>
<YR>2009</YR>
<VL>133</VL>
<PG>533-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hammar-1990" NAME="Hammar 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hammar M, Berg G, Lindgren R</AU>
<TI>Does physical exercise influence the frequency of postmenopausal hot flushes</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1990</YR>
<VL>69</VL>
<PG>409-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2010" MODIFIED="2014-11-12 13:51:01 +1300" MODIFIED_BY="[Empty name]" NAME="Huang 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-11-12 13:51:01 +1300" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Huang AJ, Subak LL, Wing R, et al</AU>
<TI>An intensive behavioral weight loss intervention and hot flushes in women</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2010</YR>
<VL>170</VL>
<NO>13</NO>
<PG>1161-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hunter-1999" MODIFIED="2014-11-12 13:51:39 +1300" MODIFIED_BY="[Empty name]" NAME="Hunter 1999" YEAR="1999">
<REFERENCE MODIFIED="2014-11-12 13:51:39 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hunter M, O-Dea I</AU>
<TI>An evaluation of a health education intervention for mid-aged women: five year follow-up of effects upon knowledge, impact of menopause and health</TI>
<SO>Patient Education and Counseling</SO>
<YR>1999</YR>
<VL>38</VL>
<PG>249-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Joshi-2011" MODIFIED="2014-11-12 13:51:56 +1300" MODIFIED_BY="[Empty name]" NAME="Joshi 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-11-12 13:51:56 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Joshi S, Khandwe R, Bapat D, et al</AU>
<TI>Effect of yoga on menopausal symptoms</TI>
<SO>Menopause International</SO>
<YR>2011</YR>
<VL>17</VL>
<PG>78-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kemmler-2004" MODIFIED="2014-11-12 13:52:57 +1300" MODIFIED_BY="[Empty name]" NAME="Kemmler 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-11-12 13:52:36 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kemmler W, Engelke K, Juergen W, et al</AU>
<TI>Exercise effects on fitness and bone mineral density in early postmenopausal women: 1-year EFOPS results</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>2002</YR>
<VL>34</VL>
<PG>2115-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-11-12 13:52:57 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kemmler W, Lauber D, Weineck J, et al</AU>
<TI>Benefits of 2 years of intense exercise on bone density, physical fitness, and blood lipids in early postmenopausal osteopenic women</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2004</YR>
<VL>164</VL>
<PG>1084-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kline-2012" MODIFIED="2013-08-07 04:29:25 +1200" MODIFIED_BY="Amanda Daley" NAME="Kline 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-08-07 04:29:25 +1200" MODIFIED_BY="Amanda Daley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kline CE, Sui X, Hall MH, et al</AU>
<TI>Dose-response of exercise training on the subjective sleep quality of postmenopausal women: exploratory analyses of a randomised controlled trial</TI>
<SO>BMJ Open</SO>
<YR>2012</YR>
<VL>2</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kok-2005" MODIFIED="2014-11-12 13:53:13 +1300" MODIFIED_BY="[Empty name]" NAME="Kok 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-11-12 13:53:13 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kok L, Kreijkamp-Kaspers S, Grobbee DE, et al</AU>
<TI>A randomized, placebo-controlled trial on the effects of soy protein containing isoflavones on quality of life in postmenopausal women</TI>
<SO>Menopause</SO>
<YR>2005</YR>
<VL>12</VL>
<NO>1</NO>
<PG>56-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krasnoff-1996" NAME="Krasnoff 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Krasnoff JB</AU>
<TI>The influence of physical conditioning on the post-menopausal hot flush</TI>
<SO>University of Oregon. Dissertation,</SO>
<YR>1996</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2009" MODIFIED="2010-03-29 10:29:25 +1300" MODIFIED_BY="jane clarke" NAME="Lee 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-03-29 10:29:25 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee SM, Kim J, Yong J, et al</AU>
<TI>Yoga for menopausal symptoms: a systematic review</TI>
<SO>Menopause</SO>
<YR>2009</YR>
<VL>16</VL>
<PG>602-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2012" MODIFIED="2013-07-19 22:38:29 +1200" MODIFIED_BY="Amanda Daley" NAME="Lee 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-07-19 22:38:29 +1200" MODIFIED_BY="Amanda Daley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee J, Kim J, Kim D</AU>
<TI>Effects of yoga exercise on serum adiponectin and metabolic syndrome factors in obese postmenopausal women</TI>
<SO>Menopause</SO>
<YR>2012</YR>
<VL>19</VL>
<NO>3</NO>
<PG>296-301</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liao-1998" NAME="Liao 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liao KLM, Hunter MS</AU>
<TI>Preparation for menopause: prospective evaluation of a health education intervention for mid-aged women</TI>
<SO>Maturitas</SO>
<YR>1998</YR>
<VL>29</VL>
<PG>215-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Llaneza-2011" MODIFIED="2014-11-12 13:53:41 +1300" MODIFIED_BY="[Empty name]" NAME="Llaneza 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-11-12 13:53:41 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Llaneza P, González C, Fernadez-Iñarrea J, et al</AU>
<TI>Soy isoflavones, diet and physical exercise modify serum cytokines in healthy obese postmenopausal women</TI>
<SO>Phytomedicine</SO>
<YR>2011</YR>
<VL>18</VL>
<PG>245-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maesta--2007" MODIFIED="2014-11-12 13:53:55 +1300" MODIFIED_BY="[Empty name]" NAME="Maesta  2007" YEAR="2007">
<REFERENCE MODIFIED="2014-11-12 13:53:55 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maesta N, Nahas EAP, Nahas-Neto J, et al</AU>
<TI>Effects of soy protein and resistance exercise on body composition and blood lipids in postmenopausal women</TI>
<SO>Maturitas</SO>
<YR>2007</YR>
<VL>56</VL>
<PG>350-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McAndrew-2009" MODIFIED="2010-03-29 10:29:32 +1300" MODIFIED_BY="jane clarke" NAME="McAndrew 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-03-29 10:29:32 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McAndrew LM, Napolitano MA, Albrecht A, et al</AU>
<TI>When, why and for whom there is a relationship between physical activity and menopausal symptoms</TI>
<SO>Maturitas</SO>
<YR>2009</YR>
<VL>64</VL>
<PG>119-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moreira-2012" MODIFIED="2014-11-12 13:54:10 +1300" MODIFIED_BY="[Empty name]" NAME="Moreira 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-12 13:54:10 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moreira H, Vaz L, Rocha J, et al</AU>
<TI>Effects of exercise training on climacteric symptoms of postmenopausal women: a randomized study</TI>
<SO>Maturitas</SO>
<YR>2012</YR>
<VL>71</VL>
<PG>S66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Moriyama-2008" MODIFIED="2014-11-12 13:54:28 +1300" MODIFIED_BY="[Empty name]" NAME="Moriyama 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-11-12 13:54:28 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moriyama CM, Oneda B, Bernardo R, et al</AU>
<TI>A randomized, placebo-controlled trial of the effects of physical exercises and estrogen therapy on health-related quality of life in postmenopausal women</TI>
<SO>Menopause</SO>
<YR>2008</YR>
<VL>15</VL>
<PG>613-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Donnell-2009" MODIFIED="2010-03-29 10:29:39 +1300" MODIFIED_BY="jane clarke" NAME="O'Donnell 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-03-29 10:29:39 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>O.Donnell, Kirwan LD, Goodman JM</AU>
<TI>Aerobic exercise training in healthy postmenopausal women: effects of hormone therapy</TI>
<SO>Menopause</SO>
<YR>2009</YR>
<VL>15</VL>
<PG>770-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ogwumike-2011" MODIFIED="2014-11-12 13:56:01 +1300" MODIFIED_BY="[Empty name]" NAME="Ogwumike 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-11-12 13:56:01 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ogwumike OO, Sanya AO, Arowojolu AO</AU>
<TI>Endurance exercise effect of quality of life and menopausal symptoms in Nigerian women</TI>
<SO>African Journal of Medicine and Medical Sciences</SO>
<YR>2011</YR>
<VL>40</VL>
<PG>187-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pangaotopulos-2004" MODIFIED="2013-08-14 03:10:12 +1200" MODIFIED_BY="jane clarke" NAME="Pangaotopulos 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-08-14 03:10:12 +1200" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Panagaotopulos SR, Welty FK</AU>
<TI>The effects of exercise and soy on hot flashes in postmenopausal women</TI>
<SO>Arteriosclerosis Thrombosis and Vascular Biology</SO>
<YR>2004</YR>
<VL>24</VL>
<PG>Pages not known</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Polis-1989" NAME="Polis 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Polis NS</AU>
<TI>Aerobic exercise: effects on selected health variables in menopausal women</TI>
<SO>Unpublished dissertation,</SO>
<YR>1989</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Riesco-2011" MODIFIED="2014-11-12 13:56:24 +1300" MODIFIED_BY="[Empty name]" NAME="Riesco 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-11-12 13:56:24 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Riesco E, Choquette S, Audet M, et al</AU>
<TI>Effect of exercise combined with phytoestrogens on quality of life in postmenopausal women</TI>
<SO>Climacteric</SO>
<YR>2011</YR>
<VL>14</VL>
<PG>573-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Riesco-2012" MODIFIED="2014-11-12 13:56:43 +1300" MODIFIED_BY="[Empty name]" NAME="Riesco 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-12 13:56:43 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Riesco E, Choquette S, Audet M, et al</AU>
<TI>Effect of exercise training combined with phytoestrogens on adipokines and G-reactive protein in postmenopausal women: a randomized trial</TI>
<SO>Metabolism</SO>
<YR>2012</YR>
<VL>61</VL>
<PG>273-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salmone-1998" NAME="Salmone 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salmone LM, Gregg E, Wolf RL, et al</AU>
<TI>Are menopausal symptoms associated with bone mineral density and changes in bone mineral density in premenopausal women?</TI>
<SO>Maturitas</SO>
<YR>1998</YR>
<VL>29</VL>
<PG>179-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Slaven-1994" MODIFIED="2014-11-12 13:56:59 +1300" MODIFIED_BY="[Empty name]" NAME="Slaven 1994" YEAR="1994">
<REFERENCE MODIFIED="2014-11-12 13:56:59 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Slaven L, Lee C</AU>
<TI>Psychological effects of exercise among adult women: the impact of menopausal status</TI>
<SO>Psychological Health</SO>
<YR>1994</YR>
<VL>9</VL>
<PG>297-303</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Steele-1997" MODIFIED="2014-11-12 13:57:16 +1300" MODIFIED_BY="[Empty name]" NAME="Steele 1997" YEAR="1997">
<REFERENCE MODIFIED="2014-11-12 13:57:16 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steele K, McKnight A, Gilchrist D, et al</AU>
<TI>A general practice trial of health education advice and HRT to prevent bone loss</TI>
<SO>Health Education Journal</SO>
<YR>1997</YR>
<VL>56</VL>
<PG>35-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ueda-2000" MODIFIED="2014-11-12 13:58:15 +1300" MODIFIED_BY="[Empty name]" NAME="Ueda 2000" YEAR="2000">
<REFERENCE MODIFIED="2014-11-12 13:58:15 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ueda MA, Tokunaga M</AU>
<TI>Effects of exercise experienced in the life stages on climacteric symptoms for females</TI>
<SO>Journal of Physiological Anthropology and Applied Human Science</SO>
<YR>2000</YR>
<VL>19</VL>
<PG>181-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ueda-2004" MODIFIED="2014-11-12 13:58:40 +1300" MODIFIED_BY="[Empty name]" NAME="Ueda 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-11-12 13:58:40 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ueda MA</AU>
<TI>12-week structured education and exercise program improved climacteric symptoms in middle-aged women</TI>
<SO>Journal of Physiological Anthropology and Applied Human Science</SO>
<YR>2004</YR>
<VL>23</VL>
<PG>143-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Villaverde-2006b" MODIFIED="2014-11-12 13:59:23 +1300" MODIFIED_BY="[Empty name]" NAME="Villaverde 2006b" YEAR="2006">
<REFERENCE MODIFIED="2014-11-12 13:59:23 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villaverde-Gutiérrez C, Araújo C, Cuz F, et al</AU>
<TI>Quality of life of rural menopausal women in response to a customised exercise programme</TI>
<SO>Journal of Sexual Medicine</SO>
<YR>2006</YR>
<VL>3</VL>
<PG>483-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-11-12 13:59:01 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villaverde-Gutiérrez C, Araújo E, Cruz F, et al</AU>
<TI>Quality of life of rural menopausal women in response to a customised exercise programme</TI>
<SO>Journal of Advanced Nursing</SO>
<YR>2006</YR>
<VL>54</VL>
<PG>11-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Villaverde_x002d_Guti_x00e9_rrez-2012" MODIFIED="2014-11-12 13:59:41 +1300" MODIFIED_BY="[Empty name]" NAME="Villaverde-Gutiérrez 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-12 13:59:41 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villaverde-Gutiérrez C, Torres G, Ábalos GM, et al</AU>
<TI>Influence of exercise on mood in postmenopausal women</TI>
<SO>Journal of Clinical Nursing</SO>
<YR>2012</YR>
<VL>21</VL>
<PG>923-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wallace-1982" MODIFIED="2014-11-12 14:00:32 +1300" MODIFIED_BY="[Empty name]" NAME="Wallace 1982" YEAR="1982">
<REFERENCE MODIFIED="2014-11-12 14:00:32 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wallace JP, Lovell C, Talano KL, et al</AU>
<TI>Changes in menstrual function, climacteric syndrome and serum concentrations of sex hormones in pre- and post-menopausal women following a moderate intensity conditioning program</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>1982</YR>
<VL>14</VL>
<PG>154</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weltman-1982" MODIFIED="2014-11-12 14:01:01 +1300" MODIFIED_BY="[Empty name]" NAME="Weltman 1982" YEAR="1982">
<REFERENCE MODIFIED="2014-11-12 14:01:01 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weltman A, Henderson N, Brammell H, et al</AU>
<TI>Relationship between training, serum, lipids and menopause</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>1982</YR>
<VL>14</VL>
<PG>154</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Welty-2007" MODIFIED="2014-11-12 14:01:14 +1300" MODIFIED_BY="[Empty name]" NAME="Welty 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-11-12 14:01:14 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Welty F, Lee K, Lew NS, et al</AU>
<TI>The association between soy nut consumption and decreased menopausal symptoms</TI>
<SO>Journal of Women's Health</SO>
<YR>2007</YR>
<VL>16</VL>
<PG>361-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilbur-2005" MODIFIED="2014-11-12 14:01:53 +1300" MODIFIED_BY="[Empty name]" NAME="Wilbur 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-11-12 14:01:53 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilbur JE, Miller AM, McDevitt J, et al</AU>
<TI>Menopausal status, moderate-intensity walking, and symptoms in midlife women</TI>
<SO>Research and Theory for Nursing Practice</SO>
<YR>2005</YR>
<VL>19</VL>
<PG>163-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2014-04-02 01:19:57 +1300" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2014-11-12 14:02:14 +1300" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Daley-2013" MODIFIED="2014-11-12 14:02:14 +1300" MODIFIED_BY="[Empty name]" NAME="Daley 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-11-12 14:02:14 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Daley AJ, Sokes-Lampard H, Thomas A, et al</AU>
<TI>Aerobic exercise as a treatment for vasomotor menopausal symptoms: randomised controlled trial protocol</TI>
<SO>Maturitas</SO>
<YR>2013</YR>
<VL>76</VL>
<PG>350-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-11-24 11:50:26 +1300" MODIFIED_BY="Helen E Nagels">
<ADDITIONAL_REFERENCES MODIFIED="2014-11-24 11:50:26 +1300" MODIFIED_BY="Helen E Nagels">
<REFERENCE ID="REF-Bahrke-1978" MODIFIED="2014-11-12 14:02:46 +1300" MODIFIED_BY="[Empty name]" NAME="Bahrke 1978" TYPE="JOURNAL_ARTICLE">
<AU>Bahrke M, Morgan WP</AU>
<TI>Anxiety reduction following exercise &amp; meditation</TI>
<SO>Cognitive Therapy and Research</SO>
<YR>1978</YR>
<VL>2</VL>
<PG>323-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bortz-1981" MODIFIED="2014-11-12 14:03:10 +1300" MODIFIED_BY="[Empty name]" NAME="Bortz 1981" TYPE="JOURNAL_ARTICLE">
<AU>Bortz WM 2nd, Angwin P, Mefford IN, et al</AU>
<TI>Catecholamines, dopamine and endorphin levels during extreme exercise</TI>
<SO>New England Journal of Medicine</SO>
<YR>1981</YR>
<VL>305</VL>
<PG>466-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Col-2009" MODIFIED="2014-11-12 14:03:21 +1300" MODIFIED_BY="[Empty name]" NAME="Col 2009" TYPE="JOURNAL_ARTICLE">
<AU>Col NF, Guthrie JR, Dennerstein L</AU>
<TI>Duration of vasomotor symptoms in menopausal women: a longitudinal study</TI>
<SO>Menopause</SO>
<YR>2009</YR>
<VL>16</VL>
<PG>453-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Daley-2006" NAME="Daley 2006" TYPE="JOURNAL_ARTICLE">
<AU>Daley AJ, MacArthur C, McManus R, et al</AU>
<TI>Factors associated with the use of complementary medicine and non-pharmacological interventions in symptomatic menopausal women</TI>
<SO>Climacteric</SO>
<YR>2006</YR>
<VL>9</VL>
<PG>336-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Daley-2007a" MODIFIED="2014-11-12 14:03:59 +1300" MODIFIED_BY="[Empty name]" NAME="Daley 2007a" TYPE="JOURNAL_ARTICLE">
<AU>Daley AJ, MacArthur C, Stokes-Lampard H, et al</AU>
<TI>Exercise participation, body mass index and health-related quality of life in menopausal aged women</TI>
<SO>British Journal of General Practice</SO>
<YR>2007</YR>
<VL>57</VL>
<PG>130-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Daley-2008" MODIFIED="2014-11-12 14:05:36 +1300" MODIFIED_BY="[Empty name]" NAME="Daley 2008" TYPE="JOURNAL_ARTICLE">
<AU>Daley A</AU>
<TI>Exercise and depression: a review of reviews</TI>
<SO>Journal of Clinical Psychology in Medical Settings</SO>
<YR>2008</YR>
<VL>15</VL>
<PG>140-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DH-2011" MODIFIED="2014-11-24 11:50:26 +1300" MODIFIED_BY="Helen E Nagels" NAME="DH 2011" TYPE="OTHER">
<AU>Chief Medical Officers of England, Scotland, Wales, and Northern Ireland</AU>
<TI>Start active, stay active. A report on physical activity for health from the four home countries&#8217; Chief Medical Officers, 2011</TI>
<SO>http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_128209. Accessed 11/2012</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eriksen-2004" MODIFIED="2014-11-12 14:07:20 +1300" MODIFIED_BY="[Empty name]" NAME="Eriksen 2004" TYPE="JOURNAL_ARTICLE">
<AU>Eriksen W, Bruusgaard D</AU>
<TI>Do physical leisure time activities prevent fatigue? A 15-month prospective study of nurses' aids</TI>
<SO>British Journal of Sports Medicine</SO>
<YR>2004</YR>
<VL>38</VL>
<PG>331-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fox-2000" MODIFIED="2014-11-12 14:07:37 +1300" MODIFIED_BY="[Empty name]" NAME="Fox 2000" TYPE="JOURNAL_ARTICLE">
<AU>Fox KR</AU>
<TI>Self-esteem, self-perceptions and exercise</TI>
<SO>International Journal of Sports Psychology</SO>
<YR>2000</YR>
<VL>31</VL>
<PG>228-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Freeman-1995" MODIFIED="2014-11-12 14:07:56 +1300" MODIFIED_BY="[Empty name]" NAME="Freeman 1995" TYPE="JOURNAL_ARTICLE">
<AU>Freeman RR, Norton D, Woodward S, et al</AU>
<TI>Core body temperature and circadian rhythm of hot flashes</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>1995</YR>
<VL>80</VL>
<PG>2354-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Freeman-2001" MODIFIED="2014-11-12 14:08:11 +1300" MODIFIED_BY="[Empty name]" NAME="Freeman 2001" TYPE="JOURNAL_ARTICLE">
<AU>Freeman RR</AU>
<TI>Physiology of hot flushes</TI>
<SO>American Journal of Human Biology</SO>
<YR>2001</YR>
<VL>13</VL>
<PG>453-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gold-2000" MODIFIED="2014-11-12 14:08:27 +1300" MODIFIED_BY="[Empty name]" NAME="Gold 2000" TYPE="JOURNAL_ARTICLE">
<AU>Gold EB, Sternfeld B, Kelsey JL, et al</AU>
<TI>Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age</TI>
<SO>American Journal of Epidemiology</SO>
<YR>2000</YR>
<VL>152</VL>
<PG>463-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gold-2004" MODIFIED="2014-11-12 14:08:45 +1300" MODIFIED_BY="[Empty name]" NAME="Gold 2004" TYPE="JOURNAL_ARTICLE">
<AU>Gold EB, Block G, Crawford S, et al</AU>
<TI>Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation</TI>
<SO>American Journal of Epidemiology</SO>
<YR>2004</YR>
<VL>159</VL>
<PG>1189-99</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Greendale-1999" NAME="Greendale 1999" TYPE="JOURNAL_ARTICLE">
<AU>Greendale GA, Lee N, Arriola E</AU>
<TI>The menopause</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>353</VL>
<PG>571-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Greene-1998" MODIFIED="2010-02-06 05:33:47 +1300" MODIFIED_BY="[Empty name]" NAME="Greene 1998" TYPE="JOURNAL_ARTICLE">
<AU>Greene JG</AU>
<TI>Constructing a standard climacteric scale</TI>
<SO>Maturitas</SO>
<YR>1998</YR>
<VL>29</VL>
<PG>25-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Heitkamp-1996" MODIFIED="2014-11-12 14:09:12 +1300" MODIFIED_BY="[Empty name]" NAME="Heitkamp 1996" TYPE="JOURNAL_ARTICLE">
<AU>Heitkamp HC, Huber W, Scheib K</AU>
<TI>Beta-endorphin and adrenocorticotropin after incremental exercise and marathon running? Female response</TI>
<SO>European Journal of Applied Physiology</SO>
<YR>1996</YR>
<VL>72</VL>
<PG>417</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hersh-2004" MODIFIED="2014-11-12 14:09:27 +1300" MODIFIED_BY="[Empty name]" NAME="Hersh 2004" TYPE="JOURNAL_ARTICLE">
<AU>Hersh A, Sfenaick M, Stafford R</AU>
<TI>National use of postmenopausal hormone replacement therapy: annual trend and response to recent evidence</TI>
<SO>JAMA</SO>
<YR>2004</YR>
<VL>291</VL>
<PG>47-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2014-11-12 14:09:41 +1300" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="BOOK">
<AU>Higgins JPT, Green S (editors)</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</SO>
<YR>www.cochrane-handbook.org</YR>
<PB>The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Holmberg-2004" MODIFIED="2014-11-12 14:10:25 +1300" MODIFIED_BY="[Empty name]" NAME="Holmberg 2004" TYPE="JOURNAL_ARTICLE">
<AU>Holmberg L, Anderson H, for the HABITS Steering and Data Monitoring Committees</AU>
<TI>HABITS (hormone replacement therapy after breast cancer&#8212;is it safe?). A randomised comparison: trial stopped</TI>
<SO>Lancet</SO>
<YR>2004</YR>
<VL>363</VL>
<PG>453-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hope-1998" MODIFIED="2014-11-12 14:10:47 +1300" MODIFIED_BY="[Empty name]" NAME="Hope 1998" TYPE="JOURNAL_ARTICLE">
<AU>Hope S, Wager E, Rees M</AU>
<TI>Survey of British women's views on the menopause and HRT</TI>
<SO>Journal of the British Menopause Society</SO>
<YR>1998</YR>
<VL>4</VL>
<PG>33-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hulley-1998" MODIFIED="2014-11-12 14:11:23 +1300" MODIFIED_BY="[Empty name]" NAME="Hulley 1998" TYPE="JOURNAL_ARTICLE">
<AU>Hulley S, Grady D, Bush T</AU>
<TI>Randomised controlled trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) Research Group</TI>
<SO>JAMA</SO>
<YR>1998</YR>
<VL>280</VL>
<PG>605-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kupperman-1959" MODIFIED="2010-03-10 23:10:52 +1300" MODIFIED_BY="[Empty name]" NAME="Kupperman 1959" TYPE="JOURNAL_ARTICLE">
<AU>Kupperman HS, Wetchler BB, Blatt M</AU>
<TI>Contemporary therapy of the menopausal syndrome</TI>
<SO>JAMA</SO>
<YR>1959</YR>
<VL>171</VL>
<PG>103-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lawton-2003" NAME="Lawton 2003" TYPE="JOURNAL_ARTICLE">
<AU>Lawton B, Rose S, McLeod D, et al</AU>
<TI>Change in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>845-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Million-Women-Study-2003" MODIFIED="2011-08-08 15:40:57 +1200" MODIFIED_BY="[Empty name]" NAME="Million Women Study 2003" TYPE="JOURNAL_ARTICLE">
<AU>Million Women Study Collaborators</AU>
<TI>Breast cancer and hormone replacement therapy in the million women study</TI>
<SO>Lancet</SO>
<YR>2003</YR>
<VL>362</VL>
<PG>419-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NAMS-2002" MODIFIED="2014-11-12 14:11:48 +1300" MODIFIED_BY="[Empty name]" NAME="NAMS 2002" TYPE="BOOK">
<AU>North American Menopause Society (NAMS)</AU>
<SO>Menopause Core Curriculum Study Guide (2nd Edition)</SO>
<YR>2002</YR>
<PB>NAMS</PB>
<CY>Mayfield, OH</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NAMS-2012" MODIFIED="2014-11-12 14:12:04 +1300" MODIFIED_BY="[Empty name]" NAME="NAMS 2012" TYPE="JOURNAL_ARTICLE">
<AU>North American Meopause Society</AU>
<TI>The 2012 Hormone Therapy Position Statement of The North American Menopause Society</TI>
<SO>Menopause</SO>
<YR>2012</YR>
<VL>19</VL>
<PG>257-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nedstrand-2005" NAME="Nedstrand 2005" TYPE="JOURNAL_ARTICLE">
<AU>Nedstrand E, Wijma K, Wyon Y, et al</AU>
<TI>Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women</TI>
<SO>Maturitas</SO>
<YR>2005</YR>
<VL>51</VL>
<PG>154-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nelson-2005" MODIFIED="2014-11-12 14:12:36 +1300" MODIFIED_BY="[Empty name]" NAME="Nelson 2005" TYPE="OTHER">
<AU>Nelson HD, Haney E, Humphrey L, et al</AU>
<TI>Management of menopause-related symptoms. Evidence report/technology assessment no.120. (Prepared by the Oregon Evidence-Based Practice Center, contract no.290-02-0024)</TI>
<SO>AHRQ publication no. 05-E016-2. Rockville, MD: Agency for Healthcare Research and Quality,</SO>
<YR>2005</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Posadzki-2013" MODIFIED="2013-08-23 23:42:09 +1200" MODIFIED_BY="Amanda Daley" NAME="Posadzki 2013" TYPE="JOURNAL_ARTICLE">
<AU>Posadzki P, Ernst E</AU>
<TI>Prevalence of CAM use by UK climacteric women: a systematic review of surveys</TI>
<SO>Climacteric</SO>
<YR>2013</YR>
<VL>16</VL>
<PG>3-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Progetto-Study-2005" NAME="Progetto Study 2005" TYPE="JOURNAL_ARTICLE">
<AU>Progetto Menopausa Italia Study Group</AU>
<TI>Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy</TI>
<SO>Maturitas</SO>
<YR>2005</YR>
<VL>52</VL>
<PG>181-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RCOG-2006" MODIFIED="2014-11-12 14:13:21 +1300" MODIFIED_BY="[Empty name]" NAME="RCOG 2006" TYPE="OTHER">
<AU>Royal College of Obstetricians and Gynaecologists. Scientific Advisory Committee</AU>
<TI>Alternatives to HRT for the management of symptoms of the menopause</TI>
<SO>Royal College of Obstetricians and Gynaecologists, www.rcog.org.uk/index.asp?pageid=1561</SO>
<YR>(accessed 23 February 2006)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reed-2013" MODIFIED="2014-11-12 14:13:41 +1300" MODIFIED_BY="[Empty name]" NAME="Reed 2013" TYPE="JOURNAL_ARTICLE">
<AU>Reed SD, Lampe JW, Qub C, et al</AU>
<TI>Self-reported menopausal symptoms in a racially diverse population and soy food consumption</TI>
<SO>Maturitas</SO>
<YR>2013</YR>
<VL>75</VL>
<PG>152-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reid-1981" MODIFIED="2014-11-12 14:13:59 +1300" MODIFIED_BY="[Empty name]" NAME="Reid 1981" TYPE="JOURNAL_ARTICLE">
<AU>Reid RL, Hoff JD, Yen SS, et al</AU>
<TI>Effects of exogenous beta h-endorphin on pituitary hormone secretion and its disappearance rate in normal human subjects</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>1981</YR>
<VL>52</VL>
<PG>1179-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rossouw-2002" MODIFIED="2014-11-12 14:14:14 +1300" MODIFIED_BY="[Empty name]" NAME="Rossouw 2002" TYPE="JOURNAL_ARTICLE">
<AU>Rossouw JE, Anderson G, Prentice RL, et al</AU>
<TI>Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomised controlled trial</TI>
<SO>JAMA</SO>
<YR>2002</YR>
<VL>288</VL>
<PG>321-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rossouw-2007" MODIFIED="2014-11-12 14:14:24 +1300" MODIFIED_BY="[Empty name]" NAME="Rossouw 2007" TYPE="JOURNAL_ARTICLE">
<AU>Rossouw JE, Prentice RL, Manson JE, et al</AU>
<TI>Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause</TI>
<SO>JAMA</SO>
<YR>2007</YR>
<VL>297</VL>
<PG>1465-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stadberg-2000" MODIFIED="2014-11-12 14:14:34 +1300" MODIFIED_BY="[Empty name]" NAME="Stadberg 2000" TYPE="JOURNAL_ARTICLE">
<AU>Stadberg E, Mattsson L, Milsom I</AU>
<TI>Factors associated with climacteric symptoms and the use of hormone replacement therapy</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>2000</YR>
<VL>79</VL>
<PG>286&#8211;92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sternfeld-1999" MODIFIED="2014-11-12 14:15:17 +1300" MODIFIED_BY="[Empty name]" NAME="Sternfeld 1999" TYPE="JOURNAL_ARTICLE">
<AU>Sternfeld Quesenberry SB Jr, Husson G</AU>
<TI>Habitual physical activity and menopausal symptoms: a case-control study</TI>
<SO>Journal of Women's Health</SO>
<YR>1999</YR>
<VL>8</VL>
<PG>115-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Viscoli-2001" MODIFIED="2014-11-12 14:16:23 +1300" MODIFIED_BY="[Empty name]" NAME="Viscoli 2001" TYPE="JOURNAL_ARTICLE">
<AU>Viscoli CM, Brass LM, Kernan WN, et al</AU>
<TI>A clinical trial of estrogen-replacement therapy after ischemic stroke</TI>
<SO>New England Journal of Medicine</SO>
<YR>2001</YR>
<VL>345</VL>
<PG>1243-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHI-2002" MODIFIED="2014-11-12 14:16:38 +1300" MODIFIED_BY="[Empty name]" NAME="WHI 2002" TYPE="JOURNAL_ARTICLE">
<AU>Writing Group for the Women's Health Initiative Investigators</AU>
<TI>Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomised controlled trial</TI>
<SO>JAMA</SO>
<YR>2002</YR>
<VL>288</VL>
<PG>321-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1996" NAME="WHO 1996" TYPE="OTHER">
<AU>World Health Organisation</AU>
<TI>Menopause. WHO Technical Report Series</TI>
<SO>World Health Organisation Scientific Group</SO>
<YR>1996</YR>
<VL>7</VL>
<PG>236-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wilbur-1992" NAME="Wilbur 1992" TYPE="JOURNAL_ARTICLE">
<AU>Wilbur J, Holm K, Dan A</AU>
<TI>The relationship of energy expenditure to physical and psychologic symptoms in women at midlife</TI>
<SO>Nursing Outlook</SO>
<YR>1992</YR>
<VL>40</VL>
<PG>269-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wyon-2004" NAME="Wyon 2004" TYPE="JOURNAL_ARTICLE">
<AU>Wyon Y, Wijma K, Nedstrand E, et al</AU>
<TI>A comparison of acupuncture and oral estradiol treatment of vasomotor symptoms in postmenopausal women</TI>
<SO>Climacteric</SO>
<YR>2004</YR>
<VL>7</VL>
<PG>153-64</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2011-08-08 15:40:23 +1200" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Daley-2007b" MODIFIED="2011-08-08 15:40:23 +1200" MODIFIED_BY="[Empty name]" NAME="Daley 2007b" TYPE="COCHRANE_REVIEW">
<AU>Daley A, MacArthur C, Mutrie N, Stokes-Lampard H</AU>
<TI>Exercise for vasomotor menopausal symptoms</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD006108"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-11-12 16:09:46 +1300" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-11-12 13:25:00 +1300" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-11-12 11:52:44 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Elavsky-2007">
<CHAR_METHODS MODIFIED="2014-11-12 11:52:44 +1300" MODIFIED_BY="[Empty name]">
<P>3-group RCT: exercise, yoga, control</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-12 11:45:56 +1300" MODIFIED_BY="[Empty name]">
<P>Low active or sedentary women 42 to 58 years of age who were experiencing vasomotor menopausal symptoms in the past month and had no history of surgical menopause and no hormone therapy use in the previous 6 months</P>
<P>A total of 164 participants were randomly assigned (exercise n = 63, yoga n = 62, control n = 39). At four-month follow-up, 16 were lost to follow-up (exercise n = 6, yoga n = 7, control n = 3). However, only 1 participant (yoga group) was excluded from the analyses (used HT); thus 163 participants were included in the analyses (161 for primary outcome). At 2-year follow-up, data were available for 134/164 randomly assigned participants. Of these, 102/134 agreed to take part in the 2-year follow-up study and 99/134 returned a follow-up questionnaire (response rate of 74%; 99/134) (exercise n = 41, yoga n = 35, control n = 23). Overall, 60.4% (99/164) provided follow-up questionnaire data 2 years after randomisation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-12 11:47:10 +1300" MODIFIED_BY="[Empty name]">
<UL>
<LI>The exercise intervention involved a low to moderate supervised walking programme. Participants met 3 times per week for 1 hour at a university centre. Participants were also encouraged to add 1 to 2 days of exercise outside of the supervised programme. Participants received individualised exercise prescriptions, as well as educational leaflets, handouts and newsletters</LI>
<LI>The yoga (Iyengar) group met twice per week for 90 minutes. Sessions were supervised by an instructor. Iyengar yoga places particular emphasis on developing strength, stamina, flexibility and balance, as well as concentration and meditation. Participants were also encouraged to practice postures outside of the supervised programme, following handouts received on a weekly basis</LI>
<LI>Wait list control</LI>
</UL>
<P>The intervention period was 4 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-12 11:47:18 +1300" MODIFIED_BY="[Empty name]">
<P>Vasomotor menopausal symptoms using the Greene Climacteric Scale. Adverse events were not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-11-12 11:49:56 +1300" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria stipulated that women had to be vasomotor symptomatic at baseline, but results indicate that based on classification of bleeding patterns (by self-report), 17% of participants would be considered premenopausal</P>
<P>Most of the sample (70%) were overweight or obese</P>
<P>More participants were purposefully randomly assigned to the exercise (n = 63) and yoga (n = 62) groups than to the control group (n = 39). Trial authors intentionally oversampled in the exercise and control groups to increase the probability of detecting a difference between outcomes in these groups, and because resources for physician cover for physiological testing were limited in the control group</P>
<P>Intervention compliance: Compliance between yoga (63%) and exercise (70%) groups did not differ significantly during the 4-month intervention period. At 2-year follow-up, physical activity was assessed in terms of energy expenditure/METs per week, but no data according to group were reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-12 11:54:44 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hanachi-2008">
<CHAR_METHODS MODIFIED="2014-11-12 11:53:39 +1300" MODIFIED_BY="[Empty name]">
<P>3-group RCT: exercise plus soy milk (n = 12 analysed), soy milk only (n = 15 analysed) and control (n = 10 analysed)</P>
<P>Study authors analysed 37 participants (exercise plus soy milk n = 12; soy milk only n = 15; control n = 10), but no data regarding dropouts or loss to follow-up were reported. Study authors did not respond to our request for further information regarding loss to follow-up. Therefore it is unclear how many women were randomly assigned</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-12 11:53:57 +1300" MODIFIED_BY="[Empty name]">
<P>Non-smoking postmenopausal women, free from disease, not taking any form of hormone treatment in the previous 12 months and not currently using soybean-derived products or herbal medications, with intact uterus and experiencing hot flushes</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-12 11:54:21 +1300" MODIFIED_BY="[Empty name]">
<UL>
<LI>Exercise intervention involved 1 hour of walking each day + soy milk</LI>
<LI>Soy milk only</LI>
<LI>Control (intervention not described)</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-12 11:54:44 +1300" MODIFIED_BY="[Empty name]">
<P>Vasomotor menopausal symptoms assessed using the Kupperman Index. Adverse events not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-12 12:04:13 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lindh_x002d__x00c5_strand-2004">
<CHAR_METHODS MODIFIED="2014-11-12 11:56:14 +1300" MODIFIED_BY="[Empty name]">
<P>2-group RCT: exercise, HT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-12 11:59:42 +1300" MODIFIED_BY="[Empty name]">
<P>Women 48 to 63 years, with vasomotor symptoms and spontaneous menopause at least 6 months previously and exercising less than 1 hour per week at baseline. Contact with the study author revealed that participants were not taking HT at baseline</P>
<P>Study originally included 75 women who were randomly assigned to exercise, 2 modes of acupuncture, oestrogen therapy (HT) or applied relaxation (n = 15 per group). We describe data here from the report that compared exercise with HT (<LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK>). Results from the other groups are presented elsewhere (<LINK REF="REF-Nedstrand-2005" TYPE="REFERENCE">Nedstrand 2005</LINK>; <LINK REF="REF-Wyon-2004" TYPE="REFERENCE">Wyon 2004</LINK>), but none of these are compared with exercise. Of women randomly assigned to exercise, 4/15 did not start the exercise programme, and 1 participant dropped out during the intervention, resulting in 10/15 receiving follow-up at 12 weeks. Only 5 of the participants randomly assigned to exercise completed follow-up at 24 week and 36 weeks. Among women randomly assigned to HT (n = 15), all completed follow-up at 12 weeks, and 9/15 completed 24-week follow-up. It is not entirely clear from the report how many women in the HT completed follow-up at 9 months, but it appears to be 9/15. In summary, 14 participants provided follow-up data at 24 weeks; therefore the <LINK REF="STD-Lindh_x002d__x00c5_strand-2004" TYPE="STUDY">Lindh-Åstrand 2004</LINK> trial was judged likely to contain high attrition bias because dropout at follow-up was substantial</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-12 12:04:13 +1300" MODIFIED_BY="[Empty name]">
<UL>
<LI>Exercise group participated in 60-minute aerobic classes of moderate intensity at a university centre for 12 weeks. Women had to attend at least 2 classes every week and to spend at least 1 additional hour/wk participating in exercise of such intensity that a shower was required afterwards</LI>
<LI>HT group was given unopposed 17&#946;-oestradiol 2 mg orally per day for 12 weeks. Thereafter it was suggested that they continue their oestrogen treatment with additional sequential progestogens given monthly</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-12 12:01:47 +1300" MODIFIED_BY="[Empty name]">
<P>Number of hot flushes per 24 hours using a diary/log book. Climacteric symptoms assessed by the Kupperman Index, although scores for vasomotor symptoms subscale were not reported.</P>
<P>Total climacteric symptom intensity and distress experienced from symptoms, although this outcome was not vasomotor symptom specific and was focused on all menopausal symptoms</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-11-12 12:02:18 +1300" MODIFIED_BY="[Empty name]">
<P>This trial report is part of a larger trial in which women were also randomly assigned to 3 other treatment groups; data from these groups are reported separately<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-12 13:12:48 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Luoto-2012">
<CHAR_METHODS MODIFIED="2014-11-12 13:08:03 +1300" MODIFIED_BY="[Empty name]">
<P>2-group RCT: exercise vs control</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-12 13:10:48 +1300" MODIFIED_BY="[Empty name]">
<P>Symptomatic women experiencing daily hot flushes, 40 to 63 years of age, not taken HT in the previous 3 months, sedentary and 6 to 36 months since less menstruation. All participants were of white ethnicity</P>
<P>Study randomly assigned 176 women equally to the exercise group or the control group; 154 received follow-up (exercise group n = 74; control group n = 80). Both trial groups received 1-hour lectures once or twice per month from the principal investigator on physical activity and general health</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-12 13:12:27 +1300" MODIFIED_BY="[Empty name]">
<UL>
<LI>Six-month unsupervised aerobic exercise training programme that included aerobic training 4 times per week for 50 minutes at moderate to hard intensity. At least 2 sessions per week needed to include walking or nordic walking</LI>
<LI>Women in the control group were asked (via questionnaire on paper) once in the middle of the trial (11&#8211;12 weeks from baseline) whether they had changed any of their physical activities or dietary habits</LI>
</UL>
<P>All participants also attended lectures (60-75 minutes) once or twice per month, which covered topics such as physical activity and general health</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-12 13:12:37 +1300" MODIFIED_BY="[Empty name]">
<P>Vasomotor symptoms measured by the Women's Health Questionnaire. Hot flushes and night sweats recorded by diary. Adverse events not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-11-12 13:12:48 +1300" MODIFIED_BY="[Empty name]">
<P>Control group attended lectures once or twice per month, which covered topics such as physical activity and general health</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-12 13:21:15 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sternfeld-2014">
<CHAR_METHODS MODIFIED="2014-11-12 13:15:03 +1300" MODIFIED_BY="[Empty name]">
<P>3-group RCT: exercise, yoga and usual care control group</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-12 13:17:25 +1300" MODIFIED_BY="[Empty name]">
<P>Women 42 to 62 years of age, late perimenopausal or postmenopausal or having a hysterectomy with FSH &gt; 20 mlU/mL and oestradiol &#8805; 50 pg/mL. To be eligible, women must have been experiencing 14 or more vasomotor symptoms per week in each of 3 consecutive weeks, as measured by daily diaries. Vasomotor symptom frequency between visits 1 and 2 no less than 50% of weekly mean in the 2 weeks before Visit 1, and symptoms rated as severe or bothersome on at least 4 occasions. Women taking HT or contraceptives in past 2 months were excluded, as were women with BMI &gt; 37. Women taking omega-3 and participating in yoga in the previous 3 months were excluded</P>
<P>355 women were randomly assigned to exercise (n = 106), usual activity (n = 142) or yoga (n = 107). Of these, 338 received follow-up (exercise n = 101, yoga n = 102, control group n = 135)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-12 13:19:03 +1300" MODIFIED_BY="[Empty name]">
<UL>
<LI>Exercise intervention consisted of 12 weeks of 3 individualised cardiovascular training sessions per week at a local leisure centre supervised by an exercise trainer. The intervention was progressive over time, from moderate to hard intensity. Sessions lasted between 40 and 60 minutes</LI>
<LI>Usual activity: This group was asked to refrain from changing physical activity behaviour during the trial</LI>
<LI>The yoga intervention involved the practice of cooling breathing exercises and 3 groups of poses (asanas). Poses were sequenced according to the principles of viniyoga to promote safety</LI>
</UL>
<P>Women were further randomly assigned (1:1) within each arm to 1.8 g/d U-3 fish oil or identically appearing placebo capsules</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-12 13:19:12 +1300" MODIFIED_BY="[Empty name]">
<P>Vasomotor symptom frequency as measured by daily diaries. Bother of symptoms as measured by daily diaries. Adverse events reported for both groups</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-11-12 13:21:15 +1300" MODIFIED_BY="[Empty name]">
<P>This was a multi-site trial. Data for the yoga group were extracted for this review from the second trial publication (Newton 2013)</P>
<P>Intervention compliance: Participants attended 8.5 (3.5) (mean (SD)) of 12 scheduled yoga sessions (ranging from 0 to 13). Women practiced at home 4.1 (2.3) times per week. On average, women did poses 2.6 (1.1) times per week and Yoga Nidra 2.3 (1.2) times per week. Adherence to the exercise intervention was assessed in several ways: attendance at 80% or more of training sessions; achievement of 80% or more of weekly energy expenditure goal; and achievement of target heart rate (+10 beats/min) for 50% or more of exercise time. Documented home-based training sessions were counted for women who were unable to attend a facility-based session. Study authors reported that 74 women adhered to the intervention (defined by training sessions), 66 women achieved the energy expenditure goal and 75 achieved the target heart rate goal. Activity behaviour outside exercise training decreased by 1.5 steps/min in the exercise group compared with an increase of 0.22 steps/min in the usual activity group (P value 0.02)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2014-11-12 13:28:37 +1300" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Aiello-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not all participants were symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-19 23:37:06 +1200" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Alfonso-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-19 23:37:06 +1200" MODIFIED_BY="Amanda Daley">
<P>Participants were not vasomotor symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 04:08:04 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Asbury-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 04:08:04 +1300" MODIFIED_BY="[Empty name]">
<P>Participants were not vasomotor symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-03-26 05:13:14 +1300" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Bergstr_x00f6_m-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-03-26 05:13:14 +1300" MODIFIED_BY="Amanda Daley">
<P>Not all participants were symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:26:09 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Booth_x002d_LaForce-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:26:09 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 04:08:15 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Boraz-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 04:08:15 +1300" MODIFIED_BY="[Empty name]">
<P>Not all participants were vasomotor symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-03-26 05:13:21 +1300" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Chatta-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-03-26 05:13:21 +1300" MODIFIED_BY="Amanda Daley">
<P>Not all participants were symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:26:13 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cohen-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:26:13 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:26:16 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cramer-2012b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:26:16 +1300" MODIFIED_BY="[Empty name]">
<P>Nor an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:26:18 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Elavsky-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:26:18 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-19 23:37:35 +1200" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Foster_x002d_Schubert-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-19 23:37:35 +1200" MODIFIED_BY="Amanda Daley">
<P>No measure of vasomotor symptoms</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:26:28 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garcia-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:26:28 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-26 20:35:56 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gonzalez-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-26 20:35:56 +1300" MODIFIED_BY="[Empty name]">
<P>Participants were not vasomotor symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-06 01:54:16 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hammar-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-06 01:54:16 +1300" MODIFIED_BY="[Empty name]">
<P>Case control study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-29 00:00:27 +1200" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Huang-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-29 00:00:27 +1200" MODIFIED_BY="Amanda Daley">
<P>12.3% of participants were taking HT at baseline. Not possible to obtain data for those participants not taking HT at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:26:45 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hunter-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:26:45 +1300" MODIFIED_BY="[Empty name]">
<P>29% of participants were taking HT at the time of the study. Not clear whether all participants were vasomotor symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-19 23:39:31 +1200" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Joshi-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-19 23:39:31 +1200" MODIFIED_BY="Amanda Daley">
<P>Participants were not vasomotor symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:26:54 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kemmler-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:26:54 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-19 23:40:01 +1200" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Kline-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-19 23:40:01 +1200" MODIFIED_BY="Amanda Daley">
<P>No measure of vasomotor symptoms</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-14 03:36:28 +1200" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Kok-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-14 03:36:28 +1200" MODIFIED_BY="Amanda Daley">
<P>No measure of vasomotor symptoms</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:27:25 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krasnoff-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:27:25 +1300" MODIFIED_BY="[Empty name]">
<P>Not clear whether all participants were symptomatic at baseline, and the study author could not be located for clarification</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:27:34 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:27:34 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT (systematic review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-14 03:36:53 +1200" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Lee-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-14 03:36:53 +1200" MODIFIED_BY="Amanda Daley">
<P>No measure of vasomotor symptoms</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Liao-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not all participants were symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:27:44 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Llaneza-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:27:44 +1300" MODIFIED_BY="[Empty name]">
<P>Unclear whether participants were symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 04:12:01 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maesta--2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 04:12:01 +1300" MODIFIED_BY="[Empty name]">
<P>Participants were not vasomotor symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:27:54 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McAndrew-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:27:54 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-29 00:00:39 +1200" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Moreira-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-29 00:00:39 +1200" MODIFIED_BY="Amanda Daley">
<P>Most participants were taking HT at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-03-26 05:13:33 +1300" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Moriyama-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-03-26 05:13:33 +1300" MODIFIED_BY="Amanda Daley">
<P>Not all participants were symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-26 20:36:23 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-O_x0027_Donnell-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-26 20:36:23 +1300" MODIFIED_BY="[Empty name]">
<P>No measure of vasomotor symptoms</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-19 23:41:16 +1200" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Ogwumike-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-19 23:41:16 +1200" MODIFIED_BY="Amanda Daley">
<P>Participants were not vasomotor symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pangaotopulos-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study not traceable by the British Library</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Polis-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not all participants were symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:28:09 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Riesco-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:28:09 +1300" MODIFIED_BY="[Empty name]">
<P>Unclear whether participants were symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-19 23:42:18 +1200" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Riesco-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-19 23:42:18 +1200" MODIFIED_BY="Amanda Daley">
<P>No measure of vasomotor symptoms</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:28:16 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Salmone-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:28:16 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:28:18 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Slaven-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:28:18 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Steele-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not all participants were symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:28:21 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ueda-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:28:21 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:28:23 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ueda-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:28:23 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-26 20:36:44 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Villaverde-2006b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-26 20:36:44 +1300" MODIFIED_BY="[Empty name]">
<P>Participants were not vasomotor symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-19 23:42:58 +1200" MODIFIED_BY="Amanda Daley" STUDY_ID="STD-Villaverde_x002d_Guti_x00e9_rrez-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-19 23:42:58 +1200" MODIFIED_BY="Amanda Daley">
<P>No measure of vasomotor symptoms</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:28:35 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wallace-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:28:35 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-12 13:28:37 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weltman-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-12 13:28:37 +1300" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 04:14:27 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Welty-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 04:14:27 +1300" MODIFIED_BY="[Empty name]">
<P>Did not include an exercise intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wilbur-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not all participants were symptomatic at baseline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2014-04-02 01:19:57 +1300" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2014-11-12 16:09:46 +1300" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2014-11-12 16:09:46 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Daley-2013">
<CHAR_STUDY_NAME MODIFIED="2014-11-12 13:28:49 +1300" MODIFIED_BY="[Empty name]">
<P>Aerobic exercise as a treatment for vasomotor menopausal symptoms: randomised controlled trial</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-04-02 01:27:19 +1300" MODIFIED_BY="Amanda Daley">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-04-02 01:27:54 +1300" MODIFIED_BY="Amanda Daley">
<P>261 inactive perimenopausal and menopausal symptomatic women not using HT</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-12 16:09:46 +1300" MODIFIED_BY="[Empty name]">
<P>2 exercise interventions: (1) exercise consultations plus DVD and written literature; (2) exercise consultations plus exercise social support groups</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-04-02 01:31:37 +1300" MODIFIED_BY="Amanda Daley">
<P>Hot flushes, night sweats, other menopausal symptoms, quality of life, depression, anxiety</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-04-02 01:29:39 +1300" MODIFIED_BY="Amanda Daley">
<P>January 2012</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-04-02 01:29:22 +1300" MODIFIED_BY="Amanda Daley">
<P>a.daley@bham.ac.uk</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-11-12 13:29:27 +1300" MODIFIED_BY="[Empty name]">
<P>Principal investigator of this trial is also the first author of this review</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-11-12 13:25:00 +1300" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-11-12 13:21:26 +1300" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 11:50:28 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elavsky-2007">
<DESCRIPTION>
<P>Participants were randomly assigned to trial groups by a computer-based statistical package</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 12:06:09 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hanachi-2008">
<DESCRIPTION>
<P>Study states it is a randomised trial and provides no other details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 12:05:49 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lindh_x002d__x00c5_strand-2004">
<DESCRIPTION>
<P>Study reports it is a randomised trial and provides no other details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:12:52 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Luoto-2012">
<DESCRIPTION>
<P>Randomisation list was computer generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:21:26 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sternfeld-2014">
<DESCRIPTION>
<P>Computer-generated dynamic randomisation algorithm was used to maintain comparability between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-11-12 13:24:40 +1300" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:23:03 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Elavsky-2007">
<DESCRIPTION>
<P>Contact with trial authors indicates that allocation was not concealed from the research team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:23:45 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hanachi-2008">
<DESCRIPTION>
<P>No information was given in the trial report to allow a judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:24:40 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lindh_x002d__x00c5_strand-2004">
<DESCRIPTION>
<P>Randomisation was performed with the use of identical, opaque, sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:13:24 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luoto-2012">
<DESCRIPTION>
<P>Envelopes were used to randomly assign participants, but no details were provided about whether they were sealed or consecutively numbered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:21:34 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sternfeld-2014">
<DESCRIPTION>
<P>Randomisation was conducted using a secure Web-based database</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-08-20 21:57:25 +1200" MODIFIED_BY="Helen E Nagels" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2014-11-12 13:21:36 +1300" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-11-12 11:51:03 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Elavsky-2007">
<DESCRIPTION>
<P>It is not possible to blind exercise interventions to participants nor to trial personnel</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-11-12 11:55:21 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hanachi-2008">
<DESCRIPTION>
<P>It is not possible to blind exercise interventions to participants or to trial personnel</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-11-12 12:07:21 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lindh_x002d__x00c5_strand-2004">
<DESCRIPTION>
<P>It is not possible to blind exercise interventions to participants or to trial personnel</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-11-12 13:13:26 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luoto-2012">
<DESCRIPTION>
<P>No information about blinding is given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-11-12 13:21:36 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sternfeld-2014">
<DESCRIPTION>
<P>Data collectors were blinded to participants' group allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2014-11-12 13:23:13 +1300" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-12 13:23:13 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elavsky-2007">
<DESCRIPTION>
<P>Study states that all medical and testing staff were blind to group allocation at outcome assessment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-12 11:55:31 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hanachi-2008">
<DESCRIPTION>
<P>Reports of the trial do not state whether outcome assessors were blinded from knowledge of which intervention participants received</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-12 12:07:34 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lindh_x002d__x00c5_strand-2004">
<DESCRIPTION>
<P>Reports of the trial do not state whether outcome assessors were blinded from knowledge of which intervention participants received</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-12 13:13:28 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luoto-2012">
<DESCRIPTION>
<P>No information about blinding is given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-12 13:21:52 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sternfeld-2014">
<DESCRIPTION>
<P>Local access to information on group assignment was limited to site staff involved in delivery of the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-11-12 13:23:55 +1300" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-12 13:23:18 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elavsky-2007">
<DESCRIPTION>
<P>161/164 women were analysed for the primary outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-12 13:23:55 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hanachi-2008">
<DESCRIPTION>
<P>It is unclear whether the 37 women analysed included all who were randomly assigned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-12 12:08:07 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lindh_x002d__x00c5_strand-2004">
<DESCRIPTION>
<P>Data are incomplete for all outcomes and were unbalanced across groups at each follow-up. Reason for missing data is likely to be related to true outcome. Only 10/15 (66%) women in exercise arm were included in the analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-12 13:14:45 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luoto-2012">
<DESCRIPTION>
<P>154/176 (88%) women were included in the analysis. Dropouts were potentially related to efficacy or adverse effects (e.g. 2 dropouts in exercise group crossed over to HT, 2 dropped out because of musculoskeletal problems, no reason was given for 9). Significant differences in age and weight were noted between dropouts and non-dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-12 13:22:18 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sternfeld-2014">
<DESCRIPTION>
<P>241/248 (97%) women in exercise vs usual care group and 237/249 in yoga vs usual care group (95%) were included in the analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2014-11-12 13:24:15 +1300" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:23:27 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Elavsky-2007">
<DESCRIPTION>
<P>Study does not report adverse events</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:24:15 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hanachi-2008">
<DESCRIPTION>
<P>Outcomes were reported in narrative form and on graphs; no raw data were suitable for analysis. Adverse events were not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 12:08:14 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lindh_x002d__x00c5_strand-2004">
<DESCRIPTION>
<P>Adverse effects were not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:14:50 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luoto-2012">
<DESCRIPTION>
<P>Adverse effects were not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:22:32 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sternfeld-2014">
<DESCRIPTION>
<P>Report includes all expected outcomes and data on adverse events</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2014-11-12 13:25:00 +1300" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 11:51:34 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Elavsky-2007">
<DESCRIPTION>
<P>Trial groups were not balanced at baseline with regard to age, socioeconomic status and number of children. High rate of refusal to participate among eligible women (204/462 refused) could potentially affect applicability of findings</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:24:26 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hanachi-2008">
<DESCRIPTION>
<P>Poor reporting: Control intervention was not described. Baseline characteristics are similar in the 2 groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:25:00 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lindh_x002d__x00c5_strand-2004">
<DESCRIPTION>
<P>High rate of cross-overs was seen in the exercise arm&#8212;only 5 women completed protocol and follow-up; 5/10 included in analysis started HT during study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:14:52 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Luoto-2012">
<DESCRIPTION>
<P>This study appears free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-12 13:22:46 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sternfeld-2014">
<DESCRIPTION>
<P>Women were further randomly assigned (1:1) within each arm to 1.8 g/d U-3 fish oil or identically appearing placebo capsules. This appears unlikely to be associated with bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2014-11-12 13:38:17 +1300" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2014-11-12 13:35:57 +1300" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2014-11-12 13:29:48 +1300" MODIFIED_BY="[Empty name]">Exercise versus control for vasomotor menopausal symptoms</TITLE>
<TABLE COLS="5" ROWS="7">
<TR>
<TD COLSPAN="5">
<P>
<B>Exercise versus control for vasomotor menopausal symptoms</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>
<B>Population:</B> women with vasomotor menopausal symptoms<BR/>
<B>Setting:</B> university<BR/>
<B>Intervention:</B> exercise versus no active treatment<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Exercise versus no active treatment</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Change in hot flushes/night sweats</B>
<BR/>Self-report<SUP>1</SUP>
<BR/>Follow-up: 3 to 24 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>Mean change in hot flushes/night sweats is<BR/>
<B>0.10 standard deviations lower in the exercise groups</B>
<BR/>(-0.33 lower to 0.13 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>454<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;</P>
<P>
<B>Low</B>
<SUP>a,b,c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD -0.10 (-0.33 to 0.13)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>*The basis for the <B>assumed risk</B> is the mean control group risk across studies. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>GRADE Working Group grades of evidence.<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Evidence self-reported: validated scales or logs/diaries used.<BR/>
<SUP>b</SUP>Recruitment, method of determining menopausal status and characteristics of included women varied.<BR/>
<SUP>c</SUP>Variation in the direction of effect.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2014-11-12 13:38:17 +1300" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES">
<TITLE MODIFIED="2014-08-21 16:24:59 +1200" MODIFIED_BY="Grade Profiler">Exercise versus yoga for vasomotor menopausal symptoms</TITLE>
<TABLE COLS="5" ROWS="8">
<TR>
<TD COLSPAN="5">
<P>
<B>Exercise versus yoga for vasomotor menopausal symptoms</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>
<B>Population:</B> women with vasomotor menopausal symptoms<BR/>
<BR/>
<B>Intervention:</B> exercise versus yoga<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Exercise versus yoga</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Change in hot flushes/night sweats</B>
<BR/>Self-report<BR/>Follow-up: 3 to 4 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>Mean change in hot flushes/night sweats<BR/>
<B>0.03 standard deviations lower in the exercise groups</B>
<BR/>(-0.45 lower to 0.38 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>279<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>Low</B>
<SUP>a,b,c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD -0.03 (-0.45 to 0.38)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>*The basis for the <B>assumed risk</B> is the mean control group risk across studies. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>GRADE Working Group grades of evidence.<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Evidence self-reported: validated scales or logs/diaries used.<BR/>
<SUP>b</SUP>Recruitment, method of determining menopausal status and characteristics of included women varied.<BR/>
<SUP>c</SUP>Variation in the direction of effect (I<SUP>2 </SUP>= 61%).<BR/>
</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2014-08-20 23:12:07 +1200" MODIFIED_BY="Helen E Nagels"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-10-22 01:19:25 +1300" MODIFIED_BY="Helen E Nagels">
<COMPARISON ID="CMP-001" MODIFIED="2014-10-09 04:55:04 +1300" MODIFIED_BY="Helen E Nagels" NO="1">
<NAME>Exercise versus control</NAME>
<CONT_OUTCOME CHI2="2.839709904421407" CI_END="0.13312684132855157" CI_START="-0.33227394363907947" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.09957355115526395" ESTIMABLE="YES" I2="29.57027065032189" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2014-10-09 04:55:04 +1300" MODIFIED_BY="Helen E Nagels" NO="1" P_CHI2="0.2417494038664929" P_Q="1.0" P_Z="0.4016503384779473" Q="0.0" RANDOM="YES" SCALE="1.1492200948210305" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.012886213172733328" TOTALS="YES" TOTAL_1="216" TOTAL_2="238" UNITS="" WEIGHT="100.0" Z="0.8386774598613864">
<NAME>Change in hot flushes/night sweats</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.11280888042731685" CI_START="-0.9185088568938615" EFFECT_SIZE="-0.40284998823327234" ESTIMABLE="YES" MEAN_1="-0.65" MEAN_2="-0.07" MODIFIED="2014-10-09 04:52:38 +1300" MODIFIED_BY="[Empty name]" ORDER="5" SD_1="1.49" SD_2="1.29" SE="0.2630960939731753" STUDY_ID="STD-Elavsky-2007" TOTAL_1="41" TOTAL_2="23" WEIGHT="17.168184927301223">
<FOOTNOTE>Controls received no active treatment</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.15788425975270248" CI_START="-0.47536887510775105" EFFECT_SIZE="-0.15874230767752429" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.05" MODIFIED="2014-05-08 17:12:56 +1200" MODIFIED_BY="Amanda Daley" ORDER="10" SD_1="0.37" SD_2="0.25" SE="0.16154713552276304" STUDY_ID="STD-Luoto-2012" TOTAL_1="74" TOTAL_2="80" WEIGHT="36.15889105754211">
<FOOTNOTE>Both arms attended a course of lectures. Controls had no other active intervention.</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.31573277133022076" CI_START="-0.2000856869914909" EFFECT_SIZE="0.05782354216936494" ESTIMABLE="YES" MEAN_1="-2.4" MEAN_2="-2.6" MODIFIED="2014-05-08 16:44:27 +1200" MODIFIED_BY="Amanda Daley" ORDER="9" SD_1="3.32" SD_2="3.54" SE="0.13158875938293302" STUDY_ID="STD-Sternfeld-2014" TOTAL_1="101" TOTAL_2="135" WEIGHT="46.67292401515667">
<FOOTNOTE>Control was usual activity. Week 12 compared to baseline.</FOOTNOTE>
</CONT_DATA>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="5" ID="CMP-001.02" MODIFIED="2014-09-02 17:17:50 +1200" MODIFIED_BY="Helen E Nagels" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Additional data: decrease in hot flushes</NAME>
<TR>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Comparison</P>
</TH>
<TH>
<P>Result</P>
</TH>
<TH>
<P>Statistical significance</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-09-02 17:17:50 +1200" MODIFIED_BY="Helen E Nagels" ORDER="4" STUDY_ID="STD-Hanachi-2008">
<TR>
<TD>
<P>Decrease in hot flushes</P>
</TD>
<TD>
<P>1. Exercise + soymilk</P>
</TD>
<TD>
<P>2. Soymilk only</P>
<P/>
<P>3. Control (no details)</P>
</TD>
<TD>
<P>Group 1. Hot flushes decreased by 83% relative to Group 3</P>
<P>Group 2. Hot flushes decreased by 72% relative to Group 3</P>
</TD>
<TD>
<P>Significant benefit for Group 1 and Group 2 versus Group 3 p&lt;0.05</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2014-10-09 04:57:12 +1300" MODIFIED_BY="Helen E Nagels" NO="2">
<NAME>Exercise versus yoga</NAME>
<CONT_OUTCOME CHI2="2.534869351879337" CI_END="0.38263408225056217" CI_START="-0.44808385923433314" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.03272488849188547" ESTIMABLE="YES" I2="60.55023509363092" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2014-10-09 04:57:12 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.11135642309488758" P_Q="1.0" P_Z="0.8772788307853299" Q="0.0" RANDOM="YES" SCALE="1.385458013417937" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.05624651241030537" TOTALS="YES" TOTAL_1="142" TOTAL_2="137" UNITS="" WEIGHT="99.99999999999999" Z="0.15441968841442447">
<NAME>Change in hot flushes/night sweats</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>yoga</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours yoga</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.16606684576643221" CI_START="-0.7409106739776321" EFFECT_SIZE="-0.2874219141056" ESTIMABLE="YES" MEAN_1="-0.65" MEAN_2="-0.22" MODIFIED="2014-10-09 04:56:26 +1300" MODIFIED_BY="[Empty name]" ORDER="18" SD_1="1.49" SD_2="1.47" SE="0.23137606785078382" STUDY_ID="STD-Elavsky-2007" TOTAL_1="41" TOTAL_2="35" WEIGHT="40.90931931981848"/>
<CONT_DATA CI_END="0.4190952216343722" CI_START="-0.13188424634036355" EFFECT_SIZE="0.14360548764700432" ESTIMABLE="YES" MEAN_1="-2.4" MEAN_2="-2.9" MODIFIED="2014-05-09 12:18:09 +1200" MODIFIED_BY="Amanda Daley" ORDER="11" SD_1="3.32" SD_2="3.61" SE="0.14055856952494827" STUDY_ID="STD-Sternfeld-2014" TOTAL_1="101" TOTAL_2="102" WEIGHT="59.09068068018151">
<FOOTNOTE>Data for Yoga group are from second trial publication, Newton 2013</FOOTNOTE>
</CONT_DATA>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2014-10-22 01:19:25 +1300" MODIFIED_BY="Amanda Daley" NO="3">
<NAME>Exercise versus HT</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="8.432009388824603" CI_START="3.1679906111753984" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="5.800000000000001" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2014-10-22 01:19:25 +1300" MODIFIED_BY="Amanda Daley" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="1.5669932412855373E-5" Q="0.0" RANDOM="YES" SCALE="18.23406931874937" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="5" TOTAL_2="9" UNITS="" WEIGHT="100.0" Z="4.319054163940092">
<NAME>Change in mean number of flushes in 24 hours</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>HT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours HT</GRAPH_LABEL_2>
<CONT_DATA CI_END="8.432009388824603" CI_START="3.167990611175398" EFFECT_SIZE="5.800000000000001" ESTIMABLE="YES" MEAN_1="-1.9" MEAN_2="-7.7" MODIFIED="2014-10-14 02:02:03 +1300" MODIFIED_BY="Amanda Daley" ORDER="6" SD_1="2.3" SD_2="2.59" SE="1.3428866089303462" STUDY_ID="STD-Lindh_x002d__x00c5_strand-2004" TOTAL_1="5" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-11-12 13:39:33 +1300" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-08-20 22:35:24 +1200" MODIFIED_BY="Helen E Nagels" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAoYAAAN6CAYAAAATrYivAACAAElEQVR42uydCdxN1f7/rzFJqSQe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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-11-12 13:25:01 +1300" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAWIAAAIXCAIAAAApOcPCAABLNUlEQVR42u2dC1xN+fr/c8lEmVKR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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2014-11-12 13:25:01 +1300" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAm8AAAEACAMAAADSomGoAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2014-11-12 13:38:56 +1300" MODIFIED_BY="[Empty name]" NO="4" NOTES="&lt;p&gt;Data from Moriyama (2008) relates to the sedentary plus placebo group in this trial. &lt;/p&gt;" NOTES_MODIFIED="2014-11-12 13:38:56 +1300" NOTES_MODIFIED_BY="[Empty name]" REF_ID="CMP-001.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison. Exercise versus control, outcome: 1.1 Change in hot flushes/night sweats.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAyEAAADgCAMAAAAjbJlNAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2014-11-12 13:39:07 +1300" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-002.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison. Exercise versus yoga, outcome: 1.2 Change in hot flushes/night sweats.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAx4AAACwCAMAAAC2GkgPAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2014-11-12 13:39:33 +1300" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-003.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison. 3 Exercise versus HT, outcome: 3.1 Change in mean number of flushes in 24 hours.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwwAAACACAMAAACROx53AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-11-12 13:41:06 +1300" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2014-08-20 22:17:37 +1200" MODIFIED_BY="Helen E Nagels" NO="1">
<TITLE MODIFIED="2014-08-20 22:17:37 +1200" MODIFIED_BY="Helen E Nagels">MDSG search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-03-26 04:08:12 +1300" MODIFIED_BY="[Empty name]">
<P>
<B>MDSG search string last searched 03.04.14</B>
</P>
<P>Keywords CONTAINS "vasomotor" or "vasomotor symptoms" or "hot flashes" or "hot flushes" or "night sweats" or "night sweats-outcome" or "Flushes" or "Flushing" or "flushing outcome" or "climacteric "or "climacteric symptoms" or "climacteric symptoms-outcome" or "climacteric symptoms - vasomotor" or  "menopausal symptoms" or "*Menopause" or "  Title CONTAINS" vasomotor" or "vasomotor symptoms" or "hot flashes" or "hot flushes" or "night sweats" or "night sweats-outcome" or "Flushes" or "Flushing" or "flushing outcome" or "climacteric " or "climacteric symptoms" or "climacteric symptoms-outcome" or "climacteric symptoms - vasomotor" or "menopausal symptoms" or"*Menopause"</P>
<P>AND</P>
<P>Keywords CONTAINS "exercise" or "Exercise Therapy" or  "yoga" or "walking" or "aerobic exercise" or Title CONTAINS "exercise" or "Exercise Therapy" or "yoga" or "walking" or "aerobic exercise"</P>
<P>
 
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2014-11-12 13:41:06 +1300" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2010-03-26 19:06:41 +1300" MODIFIED_BY="[Empty name]">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2014-11-12 13:41:06 +1300" MODIFIED_BY="[Empty name]">
<P>Database: PsycINFO &lt;1806 to February Week 4 2014&gt;<BR/>Search strategy:<BR/>1 exp Physical Education/ (3154)<BR/>2 exp Physical Fitness/ (3030)<BR/>3 exp Exercise/ or exp Aerobic Exercise/ (16253)<BR/>4 (physical$ or training or exercise$).tw. (393121)<BR/>5 (yoga or tai chi or tai ji or walking or running or jogging or swimming or cycling or bicycling).tw. (29621)<BR/>6 exp Yoga/ (954)<BR/>7 exp Walking/ (3224)<BR/>8 exp Running/ (1394)<BR/>9 exp Swimming/ (1348)<BR/>10 aerobic.tw. (2587)<BR/>11 fitness.tw. (10692)<BR/>12 or/1-11 (421747)<BR/>13 (flush$ or flash$ or sweat$ or vasomotor).tw. (10418)<BR/>14 exp Menopause/ (2863)<BR/>15 (menopaus$ or perimenopaus$ or postmenopaus$).tw. (4881)<BR/>16 climacter$.tw. (441)<BR/>17 or/13-16 (15055)<BR/>18 12 and 17 (2048)<BR/>19 random.tw. (39815)<BR/>20 control.tw. (309344)<BR/>21 double-blind.tw. (17649)<BR/>22 clinical trials/ (7328)<BR/>23 placebo/ (3706)<BR/>24 exp Treatment/ (570434)<BR/>25 or/19-24 (870514)<BR/>26 18 and 25 (747)<BR/>27 limit 26 to yr="2013 -Current" (39)</P>
<P>Database: EMBASE &lt;1980 to 2014 Week 09&gt;<BR/>Search strategy:<BR/>1 exp physical education/ (10109)<BR/>2 exp training/ (58544)<BR/>3 (physical$ or training or exercise$).tw. (979676)<BR/>4 exp fitness/ (27677)<BR/>5 exp exercise/ or exp aerobic exercise/ or exp stretching exercise/ (205535)<BR/>6 (yoga or tai chi or tai ji or walking or running or jogging or swimming or cycling or bicycling).tw. (157806)<BR/>7 exp yoga/ (3683)<BR/>8 exp Tai Chi/ (1354)<BR/>9 exp walking/ (60510)<BR/>10 exp running/ (15401)<BR/>11 exp swimming/ (14918)<BR/>12 exp bicycle/ (6032)<BR/>13 aerobic.tw. (64048)<BR/>14 fitness.tw. (45085)<BR/>15 or/1-14 (1265195)<BR/>16 (flush$ or flash$ or sweat$ or vasomotor).tw. (75639)<BR/>17 exp hot flush/ (11365)<BR/>18 exp flushing/ (13004)<BR/>19 (menopaus$ or perimenopaus$ or postmenopaus$).tw. (90733)<BR/>20 exp climacterium/ (7176)<BR/>21 exp menopause/ or exp menopause related disorder/ or exp "menopause and climacterium"/ (99278)<BR/>22 exp early menopause/ (1561)<BR/>23 exp postmenopause/ (44450)<BR/>24 climacter$.tw. (4791)<BR/>25 vasomotor.tw. (12406)<BR/>26 or/16-25 (207997)<BR/>27 15 and 26 (18964)<BR/>28 Clinical Trial/ (893833)<BR/>29 Randomized Controlled Trial/ (368808)<BR/>30 exp randomization/ (65021)<BR/>31 Single Blind Procedure/ (19116)<BR/>32 Double Blind Procedure/ (120876)<BR/>33 Crossover Procedure/ (40108)<BR/>34 Placebo/ (236677)<BR/>35 Randomi?ed controlled trial$.tw. (101620)<BR/>36 Rct.tw. (13868)<BR/>37 random allocation.tw. (1346)<BR/>38 randomly allocated.tw. (20579)<BR/>39 allocated randomly.tw. (1963)<BR/>40 (allocated adj2 random).tw. (745)<BR/>41 Single blind$.tw. (14514)<BR/>42 Double blind$.tw. (145091)<BR/>43 ((treble or triple) adj blind$).tw. (362)<BR/>44 placebo$.tw. (203019)<BR/>45 prospective study/ (266200)<BR/>46 or/28-45 (1422423)<BR/>47 case study/ (24405)<BR/>48 case report.tw. (263308)<BR/>49 abstract report/ or letter/ (907127)<BR/>50 or/47-49 (1189158)<BR/>51 46 not 50 (1384398)<BR/>52 27 and 51 (3959)<BR/>53 (2013$ or 2014$).em. (1884971)<BR/>54 (2013$ or 2014$).dp. (212803)<BR/>55 53 or 54 (1885690)<BR/>56 52 and 55 (410)</P>
<P>Database: EBM Reviews&#8212;Cochrane Central Register of Controlled Trials &lt;January 2014&gt;<BR/>Search strategy:<BR/>1 exp "Physical Education and Training"/ (1277)<BR/>2 (physical$ or training or exercise$).tw. (61997)<BR/>3 exp physical fitness/ (1836)<BR/>4 exp exercise/ (11692)<BR/>5 (yoga or tai chi or tai ji or walking or running or jogging or swimming or cycling or bicycling).tw. (9870)<BR/>6 exp yoga/ (214)<BR/>7 exp tai ji/ (133)<BR/>8 exp walking/ (2124)<BR/>9 exp running/ (1112)<BR/>10 exp jogging/ (36)<BR/>11 exp swimming/ (304)<BR/>12 exp bicycling/ (896)<BR/>13 aerobic.tw. (4058)<BR/>14 fitness.tw. (2416)<BR/>15 or/1-14 (68074)<BR/>16 (flush$ or flash$ or sweat$ or vasomotor).tw. (4227)<BR/>17 exp hot flashes/ (457)<BR/>18 exp flushing/ (139)<BR/>19 exp climacteric/ (5514)<BR/>20 (menopaus$ or perimenopaus$ or postmenopaus$).tw. (10946)<BR/>21 exp menopause/ or exp menopause, premature/ or exp perimenopause/ or exp postmenopause/ (5295)<BR/>22 climacter$.tw. (630)<BR/>23 or/16-22 (15173)<BR/>24 15 and 23 (1499)<BR/>25 limit 24 to yr="2013 -Current" (70)</P>
<P>Database: Ovid MEDLINE(R) In-Process &amp; Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) &lt;1946 to Present&gt;<BR/>Search strategy:<BR/>1 exp "Physical Education and Training"/ (13245)<BR/>2 (physical$ or training or exercise$).tw. (779516)<BR/>3 exp physical fitness/ (21299)<BR/>4 exp exercise/ (114797)<BR/>5 (yoga or tai chi or tai ji or walking or running or jogging or swimming or cycling or bicycling).tw. (131512)<BR/>6 exp yoga/ (1442)<BR/>7 exp tai ji/ (563)<BR/>8 exp walking/ (18971)<BR/>9 exp running/ (13258)<BR/>10 exp jogging/ (694)<BR/>11 exp swimming/ (18217)<BR/>12 exp bicycling/ (7443)<BR/>13 aerobic.tw. (53530)<BR/>14 fitness.tw. (38743)<BR/>15 or/1-14 (973082)<BR/>16 (flush$ or flash$ or sweat$ or vasomotor).tw. (61572)<BR/>17 exp hot flashes/ (2230)<BR/>18 exp flushing/ (1051)<BR/>19 exp climacteric/ (48213)<BR/>20 (menopaus$ or perimenopaus$ or postmenopaus$).tw. (66942)<BR/>21 exp menopause/ or exp menopause, premature/ or exp perimenopause/ or exp postmenopause/ (44796)<BR/>22 climacter$.tw. (3954)<BR/>23 or/16-22 (140049)<BR/>24 randomized controlled trial.pt. (363966)<BR/>25 controlled clinical trial.pt. (87650)<BR/>26 randomized.ab. (284281)<BR/>27 placebo.tw. (154362)<BR/>28 clinical trials as topic.sh. (167902)<BR/>29 randomly.ab. (206672)<BR/>30 trial.ti. (121423)<BR/>31 (crossover or cross-over or cross over).tw. (59389)<BR/>32 or/24-31 (900158)<BR/>33 exp animals/ not humans.sh. (3885146)<BR/>34 32 not 33 (829112)<BR/>35 15 and 23 and 34 (1878)<BR/>36 (2013$ or 2014$).ed. (1077600)<BR/>37 (2013$ or 2014$).dp. (1113935)<BR/>38 36 or 37 (1535052)<BR/>39 35 and 38 (208)</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;3 studies (from 7 reports) included in the meta-analysis&lt;/p&gt;" WIDTH="150">
<FLOWCHARTBOX TEXT="&lt;p&gt;5 studies (from 9 reports) included in the qualitative synthesis&lt;/p&gt;" WIDTH="150">
<FLOWCHARTBOX TEXT="&lt;p&gt;3 studies remaining eligible for inclusion in further updates (2014 onwards)&lt;/p&gt;" WIDTH="180">
<FLOWCHARTBOX TEXT="&lt;p&gt;Three previously included studies have now been excluded &lt;/p&gt;" WIDTH="180">
<FLOWCHARTBOX TEXT="&lt;p&gt;6 studies (from 9 reports) were included in the previous version of review (Daley 2011).&lt;/p&gt;" WIDTH="180"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
<FLOWCHARTBOX TEXT="&lt;p&gt;2 new studies eligible for inclusion&lt;/p&gt;" WIDTH="150">
<FLOWCHARTBOX TEXT="&lt;p&gt;18 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="150">
<FLOWCHARTBOX TEXT="&lt;p&gt;27 records screened&lt;/p&gt;" WIDTH="180">
<FLOWCHARTBOX TEXT="&lt;p&gt;1878 records identified through database searching&lt;/p&gt;" WIDTH="180"/>
<OUT TEXT="&lt;p&gt;9 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;16 full-text articles excluded:&lt;/p&gt;&lt;p&gt;2 = commentaries, observational studies or reviews&lt;/p&gt;&lt;p&gt;1 = duplicate abstract of another study, and not RCT&lt;/p&gt;&lt;p&gt;6 = did not measure our primary outcome&lt;/p&gt;&lt;p&gt;2 = not clear if participants were symptomatic at baseline&lt;/p&gt;&lt;p&gt;3 = not symptomatic at baseline&lt;/p&gt;&lt;p&gt;2 = taking HT at baseline&lt;/p&gt;" WIDTH="180"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>